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ABSTRACT
REGION BASED GENE EXPRESSION VIA REANALYSIS OF PUBLICLY
AVAILABLE MICROARRAY DATA SETS
Ernur Saka
April 20, 2018
A DNA microarray is a high-throughput technology used to identify relative gene
expression. One of the most widely used platforms is the Affymetrix® GeneChip®
technology which detects gene expression levels based on probe sets composed of a set of
twenty-five nucleotide probes designed to hybridize with specific gene targets.
Given a particular Affymetrix® GeneChip® platform, the design of the probes is
fixed. However, the method of analysis is dynamic in nature due to the ability to annotate
and group probes into uniquely defined groupings. This is particularly important since
publicly available repositories of microarray datasets, such as ArrayExpress and NCBI’s
Gene Expression Omnibus (GEO) have made millions of samples readily available to be
reanalyzed computationally without the need for new biological experiments. One way in
which the analysis can dynamically change is by correcting the mapping between probe
sets and targets by creating custom Chip Description Files (CDFs) to arrange which probes
belong to which probe set based on the latest genomic information or specific annotations
of interest.
vi

Since default probe sets in Affymetrix® GeneChip® platforms are specific for a
gene, transcript or exon, the analyses are then limited to profile differential expression at
the gene, transcript or individual exon level. However, it has been revealed that
untranslated regions (UTRs) of mRNA have important impacts on the regulation of
proteins.
We therefore developed a new probe mapping protocol that addresses three issues
of Affymetrix® GeneChip® data analyses: removing nonspecific probes, updating probe
target mapping based on the latest genome information and grouping the probes into region
(UTR, individual exon), gene and transcript level targets of interest to support a better
understanding of the effect of UTRs and individual exons on gene expression levels.
Furthermore, we developed an R package, affyCustomCdf, for users to dynamically create
custom CDFs. The affyCustomCdf tool takes annotations in a General/Gene Transfer
Format File (GTF), aligns probes to gene annotations via Nested Containment List
(NCList) indexing and generates a custom Chip Description File (CDF) to regroup probes
into probe sets based on a region (UTR and individual exon), transcript or gene level.
Our results indicate that removing probes that no longer align to the genome
without mismatches or align to multiple locations can help to reduce false-positive
differential expression, as can removal of probes in regions overlapping multiple genes.
Moreover, our method based on regions can detect changes that would have been missed
by analysis based on gene and transcript. It also allows for a better understanding of 3’
UTR dynamics through the reanalysis of publicly available data.
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CHAPTER 1
INTRODUCTION
Photo 51, the first X-ray diffraction image of DNA produced by Rosalind Franklin
in 1952, triggered the discovery of the DNA helix structure by James D. Watson and
Francis H. C. Crick in 1953. Subsequently, the first DNA polymerase was identified by
Arthur Kornberg in 1957. After the discovery of the DNA structure and the DNA
replication mechanism, researchers started working on gene expression analysis and
protein synthesis [1], leading to the current day fields of molecular biology and
bioinformatics.
Gene expression analysis studies the entire process of a particular worker molecule
production from the coding information contained in DNA. Technologies developed for
gene expression studies have had a huge impact on the field. Southern blotting developed
by Edward M. Southern and Sanger sequencing developed by Frederick Sanger enabled
researchers to locate particular gene or DNA samples in the genome. Northern blotting
developed by James Alwine and George Stark allowed detection of specific mRNA in a
geometric sample. Exponential amplification of DNA segments became possible via the
polymerase chain reaction (PCR) technique developed by Kary Mullis. The development
of microarrays allowed researchers to investigate thousands of gene products in parallel.
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One of the most widely used microarray platforms is the Affymetrix® GeneChip®
family of arrays. It detects gene expression levels based on probe sets composed of a set of
individual 25 base probes designed to hybridize with the specific gene targets. This
research mainly focuses on the creating a framework for computationally reanalysis of
publicly available Affymetrix® GeneChip® data based on region (UTR and individual
exon), gene and transcript through remapping probes to gene targets with created custom
Chip Description Files (CDFs). The custom CDF creation involves removing nonspecific
probes, updating probe target mapping based on the latest genome information, grouping
probes into region, gene or transcript level targets and saving updated probe-target groups
into a CDF. The unspecified probes were identified based on the mapping of probe
sequences to the genome of interest. Probe target mapping was accomplished by aligning
specific probes to genomic intervals obtained from general/gene transfer format file via
Nested Containment List (NCList) indexing. Our custom CDFs provide a way to
investigate changes appeared in the untranslated regions and exons of mRNA which data
has not been performed on a large scale with microarray datasets in addition to gene and
transcript. We also supply flexibility for creating gene of interest CDFs by allowing user
to supply annotations via GTF files.
1.1 Motivation
Our research has been motivated by the following goals:
1) Improving the accuracy of microarray by using up-to-date genomes and annotations.
Given a particular Affymetrix® GeneChip® platform, the design of the probes is
fixed based on earlier genome assemblies and annotation available at that time. Since the
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design of the first Affymetrix® GeneChip®, rapid progress has been made in genome
sequencing resulting in more accurate databases of annotated protein coding and noncoding structural genes. The significant differences between old and new genome
assemblies and annotations make it necessary to update probe-gene targeting according to
current knowledge to get more accurate interpretations from experimental results.
Affymetrix® attempts to provide compatibility between genomic changes by updating
links between probe sets and their corresponding genes/transcripts via NetAffx™[2]. Table
1 shows release dates of source databases used by Affymetrix® version 36 for both the
incorporated version and the most recently available version. In all cases, there is at least
three-year difference between the incorporated and most recent release dates which can
lead to inconsistent interpretation.
In addition, updating links between probe sets and their corresponding
genes/transcripts does not provide a solution for problems caused by individual probes such
as single nucleotide polymorphisms (SNPs) [3, 4] probes that target genes other than the
designated gene of a probe set, and probes that no longer align to a genomic location due
to refinements in genome assemblies. For example, in the Affymetrix® GeneChip® HG133 Plus 2 array, a total of 40,680 probes out of 603,158 (excluding quality control probes)
do not have a perfect match to the most recent human genome assembly (hg38).
Although the inherent effects of using dated probe gene mapping designs to
analyze microarray data sets might seem obvious, the overwhelming majority of
experimental results have only been analyzed using the original CDFs designed by
Affymetrix®. For example, as of May 2016, GEO has 120,920 samples which were
analyzed via the original Affymetrix® CDFs for the HG-U133 Plus 2 array (Table 2). On
3

the other hand, only 6,403 samples were analyzed using custom CDFs, mostly produced
by brainarray (Table 3). Given that fewer than 5% of all samples in GEO have been
analyzed by alternative CDFs, an opportunity exists to reanalyze existing datasets
according to updated transcript knowledge or functional regions of interest.
TABLE 1: Release dates of databases used by NetAffx v36 annotations and current
database versions
GEO Platform Organism
GPL570
Homo sapiens
GPL1261
Mus musculus
GPL1355
Rattus norvegicus
GPL198
Arabidopsis thaliana
Incorporation Data of Databases Common to All Four GEO Platforms
Ensembl
RefSeq
GenBank
Entrez Gene
NetAffx
Nov-15
Nov-15
Nov-15
Nov-15
Current
Apr-18
Mar-18
Feb-18
Apr-18

TABLE 2: Top Affymetrix® in situ oligonucleotide arrays found in GEO
GEO
Platform

Title

GPL570

Human Genome U133 Plus 604,258
2.0 Array
Mouse Genome 430 2.0
496,468
Array
Rat Genome 230 2.0 Array 342,410
Arabidopsis ATH1 Genome 251,078
Array

GPL1261
GPL1355
GPL198

# of Probes # of Probe Sets # of
Samples
54,675

120,920

451,01

480,87

310,99
228,10

189,12
126,24

TABLE 3: Alternative CDFs for the top Affymetrix® in situ oligonucleotide arrays found
in GEO
GEO
Platform

# of Alternative # and percent of Samples
CDFs
Using Alternative CDFs

GPL570
GPL1261
GPL1355
GPL198

54
36
12
9

6403 (5.0%)
1984 (4.0%)
460 (2.4%)
642 (4.8%)
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2) Understanding the effect of untranslated regions on gene expression levels furthermore
on diseases.
In molecular biology, even though the scaffolds of the proteins are defined by
genomic DNA during transcription, they are actually synthesized during translation based
on the intermediary template messenger mRNA using the genetic code. But regulation of
genes, which functions in the selection of produced proteins, can occur at the
transcriptional or translational level [5]. Transcription level regulation occurs through
complexes that form at transcription factor binding sites which typically found within 5′
UTRs, the upstream region of the transcription start site (TSS). On the other hand, 3’ UTRs,
which are downstream of the coding region, serve as a binding site for many translational
control mechanisms.
While microarrays have been successfully utilized for understanding differential
expression at the gene or probe set level, less attention has been given to the potential
analysis at the individual exon, alternative transcript, and untranslated region (UTR) level.
Although the selection bias of probes on the 3’ ends of genes for earlier iterations of
Affymetrix® GeneChip® designs presents limitations on the completeness of transcript
information, more recent designs allow for a more complete coverage of exons and exon
junctions. However, information concerning individual exons can still be extracted from
earlier GeneChip® designs, particularly in the 3’ UTR regions.
•

3′ Untranslated Regions (UTRs) association with gene regulation
3′ UTRs contains translational control mechanisms that include miRNA binding

sites, AU rich elements (AREs), cytoplasmic polyadenylation element (CPE) binding sites,
5

localization binding elements, zipcode binding proteins and G-quadruplex sites. Through
these mechanisms, 3′ UTRs play important role in development [6-10] embryonic axis
formation, neurogenesis, erythropoiesis, localization in the nervous system [11-16] and
cancer [17-19]. For example, cytoplasmic polyadenylation [20], which is a modification of
mRNA transcripts in the form of polyadenylated (poly(A)) tails, plays an important role
in transcription level regulation, indicating that alternative splicing in the 3′ UTR might be
associated with the changes in the coding regions thus structural changes within the 3′ UTR
will affect the expression level and localization of a gene. Over 40% of genes have been
shown to generate multiple mRNAs with variable 3′ UTR lengths [21]. These 3′ UTRs
harbor binding sites for molecules including microRNAs (miRNAs) and RNA-binding
proteins. Thus, mRNA isoforms with lengthened 3′ UTRs have increased numbers of sites
for these cis-interacting factors. The diversity of 3′ UTRs is predominantly regulated by
alternative polyadenylation (APA), which employs alternative mRNA cleavage sites that
lie progressively distal to the stop codon. APA-driven mRNA diversity is required for
normal physiology, and misregulation of this process is associated with diverse disease
state [22]. It is known that the length of the 3′ UTR (short and long 3’ UTRs) plays an
important role in localization of brain-derived neurotrophic factor (BDNF) transcripts.
Short 3′ UTR mRNAs are often localized in somata, while long 3′ UTR mRNAs localized
in dendrites [23]. Lengthening of 3′ UTRs has an effect during development. A study has
shown that in the mouse brain during embryonic and postnatal development, mRNAs have
longer 3’ UTRs than other tissues [7]. Shortening of 3′ UTRs also plays an important role.
It has been shown that tumors with shorter 3’ UTRs are more aggressive in nature, and 3’
UTRs expression signatures are being used as strong predictors of survival [24]. The
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mutations within the 3’ UTR affect the termination codon, polyadenylation signal and
change the secondary structure of the 3’ UTR. For example, aniridia disease resulting
partial in or complete loss of the iris is associated with the mutation in the stop codon (TAA
 TTA) located within the 3’ UTR of the PAX6 gene [25].
•

5′ Untranslated Regions (UTRs) association with gene regulation
The 5’ UTR is a regulatory region located at the 5’ end of the mRNA [26]. Some

of the 5’ UTR regulatory elements which cause abnormal cell function are 5’ UTR length,
5’cap structure, secondary structure, mutation in the 5’ UTR and uORFs (upstream open
reading frames). For example it was shown that the BRCA1 gene, which acts as a tumor
suppressor, is downregulated by a G to C mutation within the 5’ UTR of the gene itself
[25].
3) Taking advantage of available data in public repositories.
Since microarrays were introduced in 1995, different platforms have been
developed and used to perform lab experiments. Over two million different samples have
been produced and submitted to publicly available repositories. One of the most known
and used repositories in international public high-throughput functional genomics is the
Gene Expression Omnibus (GEO). As of April 2018, GEO has 2,455,165 samples, 97,014
series and 4,348 data sets. Each sample contains original experiment results under the
specific conditions supplied by submitter. A series is a group of related samples with the
summary of the experiment, conclusions and analysis. A data set is composed of curated
records produced by GEO staff by reassembling biologically and statistically comparable
GEO samples.
7

In microarray technology, even though the design of the probes is fixed, the
methods with which the resulting experiments can be analyzed are dynamic in nature due
to the ability to annotate and arrange probes into uniquely defined groupings. This is
particularly important since GEO contains 29,930 samples produced by Affymetrix®
GeneChips® platform as of April 2018 that can be reanalyzed computationally based on
current knowledge without the need for new biological experiments. As a case in point,
each of the four most commonly used species have samples that have been analyzed using
the original CDFs (Table 2).
1.2 Organization of the Document
This dissertation is organized in 9 chapters. Chapter 2 is a brief overview of
molecular biology. It begins with an introduction followed by the main genetic molecules
DNA, RNA and protein. Next it explains gene, gene regions and the gene expression
mechanism. It continues with the central dogma, genetic information transfer and genetic
code. It ends with alternative splicing and noncoding DNA regions. Chapter 3 explains
microarrays which mainly focuses on the Affymetrix® GeneChip® platform. It starts with
a history of gene expression tools before microarrays and continues with the basis of
microarrays; hybridization, design of DNA microarray lab experiments and type of DNA
microarray technologies. Next it explains the Affymetrix® GeneChip® technology and
ends with the data file types. Chapter 4 is the literature review of custom CDFs. It starts
with a motivation for the used custom CDFs and summaries the custom CDF design steps
of previously published works. Chapter 5 explains the alignment tool Bowtie, the interval
tree data structure and nested containment list indexing. Chapter 6 explains the protocol
used to create our custom CDFs. It starts with the removal of unspecific probes, continues
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with annotation of probes via NCList indexing and ends with probe set naming inside the
custom CDF file. Chapter 7 explains the developed R package affyCustomCdf and a
variety of files that can be created via the affyCustomCdf tool. Chapter 8 gives the
statistical and analysis results of produced human, rat and mouse custom CDFs. It also
presents the comparisons between our results, previous work and comparisons between
different types of our custom CDFs via reanalyzing publicly available microarray datasets.
Chapter 9 discusses the contributions and post dissertation work. Appendix A provides
steps for using the developed R package affyCustomCdf.
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CHAPTER 2
OVERVIEW OF MOLECULAR BIOLOGY
Molecular biology is the field of study that involves studying cell structure and
function down to the level of the individual molecules within those cells that contain the
programming for life functions [27]. Cells are the smallest living things and the basic unit
of any living organisms. They have all the properties of life such as reproduction, response
to environment signals, a need for energy, and release of waste products. All cells are built
out of similar materials (including an organism’s DNA) and function in similar ways.
Prokaryotic cells, such as bacteria and some single celled organisms, have simple
organization. They do not have a true membrane-bound nucleus and organelles. Eukaryotic
cells, such as plants, animals, and fungi are structurally complex. They contain a
membrane-bound nucleus and organelles.
The nucleus is a small spherical, dense body in a eukaryotic cell. It is called the
control center of the cell since it controls many of the activities of the cell including cell
reproduction. Contained within the nucleus are chromosomes which are microscopic,
threadlike strands composed of DNA. Regions of the DNA are gene coding segments used
by a cell to create cellular workers like proteins that control the function of a cell. The
proteins are coded by the sequence of DNA which is written in the chemical letters A, T,
C, and G. When proteins are needed, the information contained in the DNA is transcribed
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into RNA. The RNA is first processed and then transported out of the nucleus. Outside the
nucleus, the proteins are built based upon the code in the RNA. Fig. 1 shows the
relationship between nucleosome, chromosome, genes, and DNA.

Figure 1: The relationship among the nucleus, the chromosome, the gene and
DNA [28]
2.1 DNA
Deoxyribonucleic acid (DNA) is a long-term storage device of organisms to store
genetic information. It enables the transmission of genetic material from one generation to
the next by passing copies of DNA to the offspring. Stored information is read by working
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cells to build molecules, such as protein and RNA. These molecules are used to control
how an organism looks, behaves and reproduces.
DNA may be single or double stranded. A single stranded DNA molecule,
called a polynucleotide, is a chain of small molecule nucleotides. Each nucleotide is made
with three separate parts: a phosphate, sugar, and nitrogenous base (Fig. 2).
Phosphate

Nitrogen Base

5-carbon
Sugar

Figure 2: The basic unit of polynucleotide chain is the nucleotide
I. Phosphate component: The phosphate group is a phosphorus atom surrounded by four
oxygen atoms. When nucleotides are joined together to form a polynucleotide, a phosphate
group is attached to the sugar molecule of adjacent nucleotide to form the sugar phosphate
backbone.
II. Sugar component: There are two different kinds of sugars found in a nucleotide:
deoxyribose and ribose. In DNA the sugar component of the nucleotide is deoxyribose.
III. Nitrogenous base: There are five different canonical nucleotide bases. These bases
are Adenine (A), Guanine (G), Cytosine (C), Thymine (T) and Uracil (U) (Fig. 3). DNA is
composed of the four bases adenine, guanine, cytosine and thymine. These five bases can
be put into two categories: purine and pyrimidine.
Adenine and guanine are purines and have similar structure. Cytosine, thymine and
uracil are pyrimidines and have a smaller structure than the purines.
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In joining nucleotides together, the sugar part of one nucleotide connects up to the
phosphate part of the next nucleotide to produce a polynucleotide (Fig. 4).

Figure 3: Types of nitrogenous bases

Figure 4: Adjacent nucleotides connect to form a DNA polynucleotide
A polynucleotide can be any length and have any order. The end of the
polynucleotide is marked either 5’ or 3' representing the location of the hydrogen bond.
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DNA is usually written with 5' left and 3' right. Fig. 5 shows the semantic representation
and sequence of a single strand DNA.

Figure 5: Semantic representation and sequence of a single strand DNA
DNA is typically a double-stranded molecule, consisting of two complementary
strands running in opposite directions. One chain runs 5'-3' and the other runs 3'- 5'. The
two strands are connected to each other by hydrogen bonds pairing each base on one strand
to a specific partner on the other strand. These complementary base pairs are adenine (A)
- thymine (T), and guanine (G) - cytosine (C) (Fig. 6). Referring to the complementary
base pairing mechanism, the second strand is known as the reverse complement of the first
strand (Fig. 7). Complementary base pairing helps achieve direct synthesis of a
complementary strand by using one strand of DNA as a template to copy the second strand.

Figure 6: Complementary base pairs
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Figure 7: Semantic representation and sequence of complementary strands
Two complementary DNA strands are twisted to make a double helix structure
(first discovered by Watson and Crick[29]). In the helix structure, the four nucleotides
make up the stairs and strands run in opposite directions.

Figure 8: DNA double helix [30]
2.2 RNA
Ribonucleic acid (RNA) is very similar to DNA; however a few important
structural details are different. RNA is usually a single stranded molecule, while DNA is
usually double stranded. RNA nucleotides contain ribose as the sugar component while
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DNA nucleotides contain deoxyribose. Adenine, guanine, and cytosine are common bases
for both RNA and DNA. But RNA uses the nucleotide uracil, instead of thymine.
RNA plays a key role in the Central Dogma of Molecular Biology [31] which is a
pathway from DNA to proteins. Three kinds of RNA molecules perform different but
cooperative functions in protein synthesis. These are:
I. Messenger RNA (mRNA): mRNA is a single strand RNA molecule used to transfer
genetic information from DNA to ribosome via transcription. Because the information in
DNA cannot be decoded directly into proteins, DNA is first encoded into mRNA during
transcription.
Transcription of DNA to mRNA is a two-step process. First, pre-mRNA is
synthesized from one strand of a DNA using a complementary mechanism (Fig.9).

DNA

5' AG C G GT  C AA T 3'
|
|
|
|
|
|
|
|
|
|
3' T  C  G C  C AG T  T A 5'
Take complementary of the second strand
(T replaced by U because RNA has U)

Pre-mRNA

5' AG C GG U C AA U 3'
Figure 9: DNA to pre-mRNA

Pre-mRNA contains both non-coding regions (introns) and coding regions
(exons). Only exons are used to build proteins. Therefore, in the second step the introns are
removed and the exons are spliced together to form mRNA (Fig.10). Later the formed
mRNA is carried from the nucleus to the cytoplasm to be translated into a protein sequence.
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The amount of mRNA produced from DNA gives a measurement of the activity
of individual genes in a cell, since only active genes are translated to mRNA.
II. Ribosomal RNA (rRNA): Ribosomal RNA (rRNA) is a non-coding ribonucleic acid
that is an essential and functional component of ribosomes. Ribosomes are small particles
located in the cytoplasm (jelly like material that fills the cell).
As non-coding RNA, rRNA itself is not translated into a protein, but provides a
mechanism for translating mRNA into protein by interacting with the transfer RNAs during
translation.

Figure 10: DNA to mRNA
III. Transfer RNA (tRNA): Transfer RNA (tRNA) is a specialized RNA that is produced
by transcription like mRNA. tRNA functions in carrying amino acids to the ribosome to
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form proteins. tRNA has a unique three-dimensional structure that helps to perform their
function (Fig. 11).

Figure 11: tRNA structure [32]
Each tRNA molecule has an anticodon (three nucleotide sequence) and amino acid
attachment site. The anticodon is unique for each amino acid which means that each tRNA
binds a specific amino acid. During the translation of mRNA sequence to an amino acid
chain (protein), the anticodon temporally pairs with a complementary consecutive triplet,
the codon, in mRNA. At the same time the amino acid binds to tRNA by the help of
enzymes. Subsequently the bound amino acid is transferred to the ribosome, where proteins
are assembled according to the information carried by mRNA, and attached to the growing
amino acid chain.
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2.3 mRNA Structure
A processed mRNA consists of different regions as shown in Fig. 12.

Figure 12: Mature mRNA
2.3.1 Untranslated Regions (UTR)
UTRs are non-coding regions located on each side of a coding sequence on an
mRNA.
•

5 Prime UTR (5ꞌ UTR): The section of mRNA from the 5ꞌ end of the mRNA to just
before the first codon used in translation. It functions as a transcriptional regulator [33].

•

3 Prime UTR (3ꞌ UTR): The region on the mRNA from the 3ꞌ end of the mRNA. 3ꞌ
UTRs affect the produced gene expression level by the mRNA. Prior to translation
microRNAs can bind to the 3ꞌ UTR and reduce the gene expression level of mRNAs
by marking it for degradation [34]. Silencer regions in the 3ꞌ UTR inhibit gene
expression. In addition, proteins can bind to the adenylate-uridylate-rich elements (AUrich elements, AREs) located in the 3ꞌ UTR region and effect stability and degradation
rate of transcripts. Moreover, poly(A) signals contained in the 3ꞌ UTR controls the
addition of a poly(A) tail, which can be several hundred adenine bases, to the 3ꞌ end of
the mRNA.
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2.3.2 Poly(A) Tail
When transcription of a gene terminates, a long chain of adenine bases called
poly(A) tail is added to the 3ꞌ end of a messenger RNA [20]. It protects the mRNA
molecule from enzymatic degradation, makes the mRNA more stable, and allows mRNA
to be exported from the nucleus into the cytoplasm where it is translated into protein.
2.4 Protein
Proteins are the biological molecules necessary for most of the activities in
organisms including DNA replication, transportation of molecules and catalyzing
biochemical reactions (enzymes) [35]. A protein molecule is made from long chain of
amino acids. An amino acid is an organic compound which contains amine (NH2) and
carboxylic acid (COOH) functional groups, along with a side-chain or R-group what makes
each amino acid different from the others.
Proteins vary in their amino acid sequence which is encoded in the nucleic acid
sequence of their gene. A protein is formed by a multiple step process (Fig. 13). A gene in
DNA that carries the encoding of a specific protein is first transcribed into pre-messenger
RNA (mRNA) via proteins such as RNA polymerase. Later pre-messenger RNA is
processed to form mature mRNA and alternatively spliced to create different protein
isoforms from a gene. The resulting mRNA is translated into protein by the process called
translation. During translation, mRNA is read according to the genetic code. The genetic
code is the set of rules for coding amino acids from three consecutive nucleotides called
codons. For example, CAG (cytosine-adenine-guanine) codes for glutamine (Gln).
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Figure 13: Simplified diagram of protein production from DNA
A protein folds into a specific three-dimensional structure defined by the amino
acid sequence. The three dimensional structure determines the function of the protein since
proteins function via physical interaction with other molecules [36].
2.5 Chromosome
In a single human cell there are 46 chromosomes in DNA that makes 3 billion base
pairs of DNA per cell. Because each base pair is around 0.34 nanometers long, each diploid
cell contains about 2 meters of DNA. Moreover, an adult human body has about 50 trillion
cells, which means there is 100 trillion meters of DNA per human. Since the sun is 150
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billion meters away from earth, each human has enough DNA for more than 300 trips from
the earth to the sun and back [37]. To fit long DNA strands into the microscopic space of
a cell nucleus, DNA is packed into structures called chromosomes. The packing of DNA
into a chromosome is done in several steps, starting with the double helix structure of DNA.
Then, DNA is wrapped around proteins called histones. The resulting DNA protein
complex is called chromatin. The fundamental packing unit of chromatin is the
nucleosome. The nucleosome must be stable and tightly bound to compact DNA but at the
same time must allow access to the DNA for the regulatory control to ensure correct gene
expression. Eventually nucleosomes are folded and form chromosomes (Fig. 1).
2.6 Gene
A gene is a continuous subpart of a single stranded DNA molecule. One strand of
DNA contains many genes. All of these genes are needed to give instructions for how to
build all of the proteins for an organism. Fig. 1 shows the relationship between a gene and
DNA.
2.7. Gene Regions
A gene consists of different regions and can be classified as protein coding genes
or non-coding RNA genes. A nucleotide sequence in the gene may be in one of the
following regions:
2.7.1 Intron
An intron is a non-coding nucleic acid sequence region. It is located inside of a
gene and the corresponding RNA transcript of most of the organisms. The amount and size
of introns varies according to organism, gene and location of a gene in the cell. They are
removed during alternative splicing and do not have an effect on the final product of the
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gene. But it does not mean that they do not serve a purpose. After alternative splicing they
may produce non-coding RNA molecules [38]. Furthermore, some introns encode specific
proteins by themselves.
2.7.2 Exon
An exon is a coding nucleic acid sequence part of a gene. It contains information
for protein synthesis. After introns are removed, exons join together during alternative
splicing and create mature mRNA.
2.7.3 Open Reading Frame (ORF)
An open reading frame is the part of the reading frame that starts with start codon
ATG (Met) and ends with one of the three stop codons (TAA, TAG, TGA). A reading
frame is a sequence of nucleotide triplets (codons) which contains directions for making a
protein. In a single strand of nucleic acid there are three possible reading frames, each
beginning from a different nucleotide in a triplet.
In double stranded DNA, an additional three possibilities come from the
complementary sequence. Gene prediction starts with an open reading frame search.
2.7.4 Coding sequence (CDS)
CDS is a region of DNA that is known to be translated to a protein. It is also
called the coding sequence. A CDS begins with start codon ATG next to the 5` end and
terminates with one of the three stop codons (TAA, TAG, TGA) next to 3` end. The main
difference of CDS from ORF is they are known to be transcribed into a protein, neither the
gene nor the protein must be known but ORFs are potential protein coding regions and may
also contain non-coding RNA.
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5 … ׀agtacgctgaatagcgtattttcatttgaggacgatgtataa … 3’
Frame 1

agt acg ctg aat agc ttt tca ttt gag gac gat gta taa

Protein Sequence
Frame 2

S T

L N S F S F E

D D V *

gta cgc tga ata gcg tat ttt cat ttg agg acg atg tat

Protein Sequence

V R *

I A Y F H L R

T M Y

Frame 3

tac gct gaa tag cgt att ttc att tga gga cga tgt

Protein Sequence

Y A

E *

R I F I

*

G R C

The sample DNA sequence is showing 3 different reading frames in the forward
direction. Open frame 1 starts with “a”, open frame 2 starts with “g”, open frame 3
starts with “t” and “*” indicates the stop codons. Each frame line followed by
translated amino acid sequence. The possible longest ORF is in open frame 1.
Figure 14: Possible open reading frames from a DNA sequence
2.8 Gene Expression
Almost every cell in an organism contains a complete set of genes but each gene
in the set is not used by a specific cell due to the effect of cell type, cell development and
environmental changes. This important mechanism of cells relates the importance of
differential gene expression.
The separation of active and inactive genes is carried out by a process known as
gene regulation. When a gene is turned on, the molecular product of this gene can be
synthesized, and subsequently identified as expressed. Oppositely when a gene is turned
off, the molecular product of this gene cannot be synthesized and the gene is identified as
unexpressed.
Gene expression analyses reveals the function of genes, cell-cell differences, cell
interactions and where, when and in which conditions a gene expressed. The expression
24

analyses of many genes can be determined by measuring mRNA levels with multiple
techniques including in situ hybridization and microarrays.
2.9 Central Dogma of Molecular Biology
In 1958, Francis Crick used the term “Central Dogma” for the idea of one-way
genetic information flow between macromolecules and he explained it as “once
‘information’ has passed into protein it cannot get out again. In more detail, the transfer of
information from nucleic acid to nucleic acid or from nucleic acid to protein may be
possible, but transfer from protein to protein, or from protein to nucleic acid is impossible”
[31].
In the Central Dogma there are three major classes of macromolecules: DNA, RNA
(both nucleic acids) and proteins [39]. By using the three macromolecules, nine
information transforms are defined and classified into three groups: general, special and
unknown transfers. The general transfers are: DNADNA, DNARNA and
RNAProtein transforms. They usually occur in most cells. The special transfers are:
DNAProtein, RNADNA and RNARNA. They only occur in a laboratory or in the
case of some viruses under specific conditions. The unknown transfers are: ProteinDNA,
ProteinRNA and ProteinProtein. Fig. 15 is taken from original work of Francis Crick
[40] which shows the diagrams for the transfer of information.
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Figure 15: Central Dogma of Molecular Biology [40]
2.9.1 General Transfers
a) DNA replication
DNA replication is the process that a cell uses to copy DNA with the help of
enzymes and proteins. In order to start DNA replication, the double stranded DNA helix
must be opened. Helicases and single strand DNA binding proteins unwind the DNA into
two single strands. After that, DNA polymerase III, I, ligase and primase proteins work
together to build copies of template DNA (Fig 16).
b) Transcription
The process of creating a complementary RNA from a DNA template is called
transcription (Fig. 17). In protein coding regions, the resulting complementary RNA copy
is called mRNA. mRNA naturally exists in single stranded forms and acts as a template for
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protein synthesis. The enzyme called RNA polymerase transcribes DNA to mRNA. After
transcription, mRNA is moved to the ribosome where it is translated into protein.

Figure 16: DNA replication [41]
Transcription has main three steps:
I. Initiation: DNA is transcribed by the enzyme RNA polymerase. In this step RNA
polymerase attaches to the DNA at a specific area called the promoter region by using
specific nucleotides sequences. Promoters are the regions of the DNA that signal initiation
of transcript.
II Chain elongation: RNA polymerase moves along the one strand of the DNA, the
template strand, and creates mRNA.
III. Termination: When the RNA polymerase reaches the termination sequence, it releases
the mRNA and detaches from the DNA.
c) Translation
Translation is the part of protein synthesis that produces a specific amino acid chain
by decoding the mRNA generated by transcription (Fig. 18). It is performed by the
ribosome which is a component of a cell.
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Figure 17: Transcription [42]
Translation has main four steps:
I. Activation: Amino acids are attached to the tRNA.
II. Initiation: mRNA binds to the small subunit of the ribosome and the ribosome moves
along the mRNA until it reads the start codon AUG. At that point in time, the large subunit
of the ribosome attaches to allow starting of translation and start codon AUG binds with
the tRNA that has anticodon UAC and the bound amino acid methionine.
III. Elongation: In elongation another tRNA attaches to the ribosome next to the start
codon and binds a new amino acid to the first one to form polypeptide chain. The binding
process repeats until a full polypeptide chain is formed according to the sequence of bases
in the mRNA.
IV. Termination: When the ribosome reads a stop codon (UAA, UAG, UGA) on the
mRNA, the completed protein is released from the final tRNA then the last tRNA and the
mRNA are detached from the ribosome.
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Figure 18: Translation [43]
2.9.2 Special Transfers
a) Reverse transcription
The transfer of information from RNA to DNA is reverse transcription. It occurs in
retroviruses (RNA virus), such as HIV or retrotransposons (amplifying the genetic
elements) and telomere (a region of repetitive DNA sequence at the end of a chromosome)
synthesis.
b) RNA replication
Producing a new RNA from RNA is RNA replication. It is used to reproduce some
viruses. These viruses can be double-stranded or single-stranded RNA [44]. Doublestranded RNA viruses make single-stranded RNA molecules from the double-stranded
RNA molecules. Single-stranded RNA viruses are divided into two groups: negative-sense
single-stranded RNA viruses and positive-sensed single-stranded RNA viruses. The RNA
molecule of negative-sense viruses cannot be read directly to create proteins. First,
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complementary RNA is created and used to produce viral proteins. RNA molecules of
positive-sensed single stranded RNA viruses can be read directly for the synthesis of viral
proteins.
c) Direct translation from DNA to Protein
Translation of proteins directly from DNA has been shown in cell-free systems.
DNA is obtained from mammalian cells and added into an Escherichia coli cell-free
system. Later antibiotics are added to the system and protein is produced directly from
single stranded DNA [45].
2.10 Genetic Code
When the information is needed to make a protein, one strand of a DNA molecule
is transcribed to mRNA. Later the mRNA is translated to a protein composed of amino acid
molecules. Since there are only four bases in mRNA to code the 20 amino acids, more than
one base must be used to specify an amino acid. Even using two bases to code all 20 amino
acids is not enough (4x4 = 16). Therefore, three bases are required to decode one amino
acid. A single set of these three bases is called a codon and the set of all possible
combinations of three bases called the genetic code first discovered by Marshall Warren
Nirenberg [46] in 1968 (Table 4). There are 64 (4x4x4) different combinations or codons.
Three of them are stop codons which gives a signal to terminate the amino acid chain being
synthesized on the ribosome. The start codon is AUG. It also encodes the amino acid
methionine. The rest of the amino acids are encoded by the each of the remaining sixty
codons.
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TABLE 4: Genetic code

The following is an example to show how codons decoded from mRNA to amino
acid chain. “*” denotes stop codons and the sequence is partial, where it assumes that the
start codon already passed.
DNA: UUA ACA UGA AAG AUG ACA UAC GAU AGC GAU GAU CGA CGC
Leu Thr
L

T

*

Lys

*

K

Met Thr
M

T

Tyr Asp Ser Asp Asp
Y

D

S

D

D

Arg Arg
R

R

2.11 Alternative Splicing
Alternative splicing is a process which increases the biodiversity of proteins by
allowing multiple proteins to be created from one section of a DNA. It is also called
differential splicing.
A gene is first transcribed into a pre-messenger RNA which is a copy of a specific
section of DNA containing both introns and exons. After introns are removed from pre31

mRNA, exons join together by the alternative splicing process. During alternative splicing,
exons of a gene can be spliced together in different ways to create different mRNAs from
that gene. As a result, the proteins coded by alternatively spliced mRNAs contain different
amino acid sequences and often function differently.
Alternative splicing events can be categorized into five main types:
•

Exon skipping: An exon of a gene can be excluded from the produced mRNA.

•

Intron retention: An intron can remain in the produced mRNA.

•

Mutually exclusive exons: One of two exons is included in the produced mRNA, not
both.

•

Alternative donor site: An alternative 5ꞌ splice junction is used.

•

Alternative acceptor site: An alternative 3ꞌ splice junction is used.

Figure 19: Alternative splicing types
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2.12 Transcript
A single gene can produce multiple proteins by using alternative splicing to create
different transcripts. As a result, transcripts of the same gene differ in the exons used to
construct the corresponding mRNA. For example, table 5 provides the transcript list of the
gene CTLA4 and the proteins that transcripts produce. From the CTLA4 gene, a cell can
have five different transcripts and produce four different proteins.
TABLE 5: Transcripts of the Gene CTLA4
Name

Ensembl Transcript ID Protein

CTLA4-001
CTLA4-005
CTLA4-002
CTLA4-004
CTLA4-003

ENST00000302823
ENST00000295854
ENST00000427473
ENST00000472206
ENST00000487393

223aa
174aa
137aa
79aa
No protein

2.13 Noncoding DNA
Noncoding DNA is the region of DNA that does not contain protein coding
information [47]. Although initially these regions were thought to be non-functional and
therefore called junk DNA, noncoding DNA does have important functions in the genome
such as they control when, where and what level gene expressed via promoters, enhancer
and silencer regions. These regions may also produce non-coding RNAs (miRNAs,
lncRNAs, sncRNAs, …) The proportion of the noncoding DNA within organisms varies.
For example, in the human genome 98% or more of the genome is noncoding, whereas in
prokaryotes only 20% or less of the genome is noncoding.
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2.13.1 Promoter
Promoters are adjacent to a gene near the 5`end of the transcription initiation
site. They indicate the start point of gene transcription and provide a binding site for RNA
polymerase. RNA polymerase initializes the transcription by binding to the promoter
sequence. Many eukaryotic genes have an A-T rich promoter sequence called a TATA box.
This name comes from the preserved sequence most commonly observed TATAAA.
During transcription a TATA binding protein binds to the TATA-box to unwind DNA and
the bend it through 80o.About 24% of human gene have TATA-box.
2.13.2 Enhancer
Enhancers are DNA sequences that increase the expression of a specific gene
when bound by transcription factor proteins (activator) [48]. Enhancer sequences can be
located in both forward and backward direction. They can be located in the intron of the
gene being regulated or up to one millions of base pairs away from the gene. The long
distance between the enhancer and the gene does not affect the function of enhancers
because of the folded and coiled chromosome structure of DNA. Spatially they can be
located near the transcription start site in chromosome structure.
2.13.3 Silencers
Silencers are DNA sequences that block the expression of a specific gene when
bound by proteins (repressor) [49]. They are mostly located in the upstream of the targeted
gene. The distance ranges from 20 base pairs to 200 base pairs upstream of a gene. Some
silencers can be also located in the intron or exon of the targeted gene or in the 3ꞌ UTR of
mRNA.
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CHAPTER 3
MICROARRAYS
Curiosity concerning the building blocks of life has led to the development of
technologies that have had huge impact on the fields. In the 1970’s Edward M. Southern
developed the technique of Southern blotting to locate particular gene or DNA sample in
the genome via gel electrophoresis and probe hybridization [50]. In 1977 Frederick Sanger
developed the Sanger sequencing method to determine the sequence of DNA by a chain
termination technique based on the use of dideoxynucleotides in addition to the normal
nucleotides found in DNA [51]. In the same year, James Alwine and George Stark
developed the northern blotting technique to detect specific mRNA in a sample [52]. In
1983 Kary Mullis developed the polymerase chain reaction (PCR) technique to allow
exponential amplification of DNA segments (thousands to millions of copies of a particular
DNA sequence) [53]. Shortly after, PCR became a fundamental technique used in many
medical and biological laboratory protocols. In terms of gene level analysis, researchers
were using all these methods to work on one specific gene product per experiment. In 1995
Schena et al. published the first paper about DNA microarray technology which allows
parallel analysis and investigation of thousands gene products using known sequence data
that is complementary to the gene of interest [54]. More recent advances allow scientists
to investigate the whole genome with or without prior information via next generation
sequencing.
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3.1 DNA Microarray
A DNA microarray (DNA chip or biochip) is a technology used to identify and
measure the level of mRNA present in prokaryotic and eukaryotic DNA. It is a solid surface
usually a glass, microscope slide or a silicon chip with fixed locations called cells, spots or
features [55]. The spots contain millions of identical selected oligonucleotides called
probes (Fig. 20).

Figure 20: Microarray features and probes
Each probe corresponds to a fragment of genomic DNA, cDNAs, PCR products or
chemically synthesized oligonucleotides of up to 800 bases. These oligonucleotides are
complementary to a gene of interest such as transcripts or exons. In microarrays, one or
more oligonucleotides group together and represent a gene of interest. Some microarray
platforms use microscopic beads in place of solid surfaces.
Microarrays have been used to identify relative gene expression to learn about cell
functions, cell differentiation, genotyping, single nucleotide polymorphisms (SNPs), effect
of treatment over diseases, changes of a particular gene involved in a disease and
polymorphisms or mutations within a population.
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3.1.1 Hybridization
Nucleic acid hybridization is the basis of microarrays [56]. It is the process in which
similar single stranded nucleic acid sequences interact and form hydrogen bonds between
complementary bases adenine (A) - thymine (T) and guanine (G) - cytosine (C). It can
happen between DNA/DNA, RNA/RNA, DNA/RNA and short oligonucleotides.
Through nucleic acid hybridization, the degree of similarity between two nucleic
acid strands can be measured and the complementary sequences of interest (targets) can be
identified. In a microarray experiment, hybridization happens between probes and
complementary target mRNAs which were obtained from test samples.
3.1.2 DNA Microarray Experiment
A microarray experiment starts with sample extraction from two different subject
cells to be compared such as treated-untreated, healthy-diseased, and mutant-wild type.
Subsequently samples are labeled. The resulting labeled samples are called targets. Once
samples are prepared they are diffused over the microarray. There are two major types of
DNA microarrays: one-color and two-color. When one-color microarray is used, samples
are labeled with a single dye (such as phycoerythrin, cyanine-3 (Cy3), cyanine-5 (Cy5) or
biotin) and hybridized to separate microarrays. When two-color microarrays are used,
samples are labeled with two different fluorescent dyes and hybridized together on a single
microarray. To remove unbound targets, the array is washed after hybridization.
One-color microarrays are also called single-channel microarrays. Since only a
single dye is used and each sample hybridized to different microarrays, the obtained data
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gives the estimation of absolute value of each gene’s expression for each sample. Some of
the benefits of using one-color system are:
•

Comparing the absolute values of gene expression between different experiments
is easier even when the experiments are done in different times and locations.

•

An abnormal sample cannot affect the other samples’ raw data because each sample
is hybridized to a separate microarray.

•

When the experiment becomes more complicated such as effect of treatment over
time, one-color microarray is usually advisable.

Figure 21: One-color Affymetrix® GeneChips® microarray experiment diagram
In a two-color microarray, samples hybridize on the same microarray therefore it
estimates the gene expression concentration ratios (each gene up or down regulated). Fig.
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22 shows a schematic for a two-color microarray experiment that is designed to compare
experimental sample (cancer cell) representing the expression pattern of genes in a specific
set of conditions with a control sample (normal cell) representing all the genes that are
expressed in the cells to be analyzed.

Figure 22: A typical two-color microarray experiment diagram
Multiple steps are involved in a two color microarray experiment.
1. Each experiment starts with isolation of mRNAs that represent the amount of genes
expressed at the time of sample collection from the experimental sample. For example,
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cancer cells and a control sample (normal cells). The success of the experiment depends
on the quality of the extracted mRNAs.
2. Next, the extracted mRNAs are converted into complementary DNA (cDNA) with the
help of a reverse-transcriptase enzyme and labeled with a different fluorescent cyanine
dyes (Cy3 and Cy5) to track the cDNAs coming from different samples.
3. The labeled experiment and control cDNA are mixed together, and then purified. After
purification, the mixed labeled cDNA is hybridized to microarray. The microarray is
washed to remove any labeled cDNA that did not hybridize on the microarray and
heated to reduce cross hybridization. Each labeled cDNA only binds to its
complementary target sequence on the microarray.
4. In the final step, an image of the microarray surface is produced by scanning to
determine how many labeled cDNA probes bound to target spots in the microarray. In
this experiment, red spots on the microarray represent genes upregulated compared to
normal samples, green spots represent genes that are downregulated in the cancer
sample, and yellow spots represents genes that active in both cancer and normal
samples. The upregulated and downregulated genes can be further investigated with
data mining techniques such as clustering.
In two-color microarray experiments dye bias may affect the identification of
differentially expressed (up-regulated) genes and increase the false positive and negative
results. The most common approach to correct dye bias is dye swap design. In dye swap
design, the initial experiment and control samples are labeled with Cy3 and Cy5 and then
hybridized on a chip. Later on, the process is repeated by switching the dyes of the two
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samples. The results of two samples are averaged and used to identify differentially
expressed genes.
3.1.3 Experimental Variations in Microarray Platforms
The purpose of a microarray experiment is measuring changes of mRNA levels
between different state of interests such as cancer cell versus non-cancer cell to detect
significant changes between states by applying analysis algorithms. But a detected
significant change may not always be real. The significant change might be result of a
random change, systematic bias in the biology, study, or samples [57] which is explained
by computer science originated principal “garbage in, garbage out” that the quality of the
analysis output received from a biological experiment depends on the quality of the
experimental data. Thus, it is important to make sure that steps taken during the microarray
experiment do not introduce deviations over the mRNA changes originated by the state
changes of interests [58]. For example, biologist must make sure samples are not
contaminated, and signals are not coming from other forms of RNAs included in the
samples addition to mRNAs of actual interest of samples. This can be performed by
biologist having control over all stages of experiments and analysis, using replicates and
cooperating their biological knowledge with the data they are studying via microarrays.
They can use mean, median standard deviations values to detect outliers, scatter plots and
histograms to observe what is accruing in a microarray.
3.1.4 Types of the DNA Microarrays Based on Technology
Microarray fabrication varies based on the probe type, solid surface used, probe
addressing method and target detection [59]. Different technologies are used to fabricate

41

microarrays.
Printed Microarrays: In the first microarrays chemically, synthesized oligonucleotides
were printed or spotted onto very fine solid surface usually a glass via either noncontact or
contact printing. In noncontact printing, the probe liquid droplets are applied onto
microarray surface by the same technology used for computer printers. In contact printing,
print pins are used to apply probes directly into a specific spot on the surface. Probes in
printed microarrays are either double-stranded DNA (dsDNA) or oligonucleotide. dsDNAs
range from 200 to 800 bases. Oligonucleotides range from 25 to 80 bases.
In Situ-Synthesized Oligonucleotide Microarrays: In situ-synthesized arrays are highdensity DNA microarrays. The solid surface used for in situ-synthesized microarrays is
typically a quartz wafer or glass. Probes in the arrays are chosen from oligonucleotides.
Oligonucleotides are directly synthesized on the microarray surface. The manufactured insitu-synthesized microarrays are Agilent, Roche NimbleGen and Affymetrix®
GeneChips®. Agilent uses a non-contact industrial inkjet printing process to spot
oligonucleotides onto specially-prepared glass slides. Agilent probe length is 60 bases and
most genes represented by single probe rarely by couple of probes. Agilent technology
places all four nucleosides simultaneously onto glass slide in repeated cycles of base by
base printing, requiring only one synthesis cycle per layer which leads to having longer
and more specific probes. Roche NimbleGen uses maskless photo-mediated synthesis.
Probe length ranges from 60 to 100 bases. Currently Roche NimleGen arrays are not
available. Both Agilent and Roche NimbleGen allow multicolor experiment.
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Alternative to Agilent and Roche NimbleGen arrays is Affymetrix® GeneChips®
which is the most widely used array. Affymetrix® GeneChips® use semiconductor-based
photolithography to construct individual probes of length 25 bases. Different than Agilent,
multiple probes represent a gene. Affymetrix® develops and commercializes variety of
arrays for plants, animals and microorganisms. In addition to predesigned arrays, they
provide MyGeneChipTM service where researchers can design their own arrays for
specialized studies. Data formats used by Affymetrix® are very well standardized. They
also provide necessary experiment reagents, tools and software to obtain and analyze the
results. Affymetrix GeneChips® are limited to one color based on a biotin labeling.
3.2 Affymetrix® GeneChips®
Affymetrix® GeneChips® are the most commonly used prefabricated arrays for
gene expression analysis. In Affymetrix® GeneChips® 11-20 probes, each of them 25
nucleotides length, form a probe set and represent transcript variants of a gene. Probes are
chosen from the region of a gene that has the least similar nucleotide sequence to other
genes [56] and placed onto a silica wafer substrate via a photolithography technique as
probe pairs (Fig. 23). Each probe pair has one perfect match (PM) probe and one
mismatched probe (MM). In the most recent Affymetrix® GeneChips®, the MM probes
are not used therefore they do not have probe pairs.
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Figure 23: Affymetrix® GeneChips® microarray design
PM probes have an exact complementary sequence to the transcript of a gene based
on a reference genome (Fig. 24). Each MM probe differs from the perfect match probe by
a complementary base located in the middle of a probe sequence (13th base). PM probes
help to measure the expression level of gene transcripts, while MM probes help to inspect
PM probe and detect cross hybridization events and background signals.

Figure 24: Affymetrix® GeneChips® probe selection and perfect match (PM), mismatch
(MM) probe sets
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3.2.1 Array Design
The successful Affymetrix® GeneChip® array design requires selection of unique
multiple probes for each transcript. Affymetrix® GeneChip® probe set design involves
collecting sequences, annotating sequences via clustering, selecting a single sequence that
represents the cluster and tiling this sequence into 25 base probes.
Probes are selected from consensus or exemplar sequences. The strategy for probe
selection regions varies according to the purpose of the array. Some arrays may examine
the gene expression in the level of exons and isoforms others may focus on polyadenylation
sites. In the HG-U133 arrays more than one probe selection regions were selected in order
to cover alternative polyadenylation sites. To decide the probe selection regions, potential
transcript ends were identified by any of the following criteria (Fig. 25):
•

The 3ꞌ end of a potential full length member sequence (RefSeq and complete CDS
mRNA sequences).

•

A set of eight or more ESTs ending at the same position.

•

3ꞌ end of the consensus sequence, a sequence obtained from the sequence of the
cluster members.

Later on, probes were selected from the 600 bases most nearest to the 3ꞌ end of exemplar
or consensus sequence (Fig. 25). In the case of selecting probes within the putative
transcript ends, the exemplar mRNA sequence is used. For all other transcript ends the
consensus sequence is used. When the orientation of cluster is unknown or uncertain the
probes were selected from both ends of the sequence.

45

Figure 25: Affymetrix® GeneChips® Human Genome U133 multiple probe selection
regions (Figure adopted from Array Design for the
GeneChip® Human Genome U133 set technical note [60] )

Figure 26: GeneChips® Human Genome U133 arrays transcript, consensus sequence,
and probes relationship
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In the human Exon 1.0 arrays probes were selected from exons of the consensus
sequence (Fig. 26).
Due to multiple potential probe selection regions, some heuristic rules are applied
to give priority for well annotated and strongly supported regions so they can be presented
in the array. The regions represent the mRNAs, annotated as containing the complete
coding sequence and 3′ untranslated sequences. Evidence of polyadenylation, the size of
cluster, orientation and genomic mapping were used for EST-only clusters prioritization
decisions.
The heuristic probe selection strategies were intended to select probes unique to a
single transcript or common among a small set of transcripts variants, but the hybridization
characteristic of probes was not considered. With the designed technique for HG-U133,
the probe binding characteristic was examined with multiple linear regression models
based on a nucleic acid duplex formation thermodynamic model. The technique predicts
the probe binding affinity and linearity according to the varying target concentrations.
After probes were selected, they were grouped together to form a probe set. The
HG-U133 set contains 11 probe pairs per probe set. The older version has 16-20 probes per
probe set. In human genome U133 Plus 2.0 arrays, the probe set names were marked via
suffixes (Fig. 27). If all probes were perfectly matched to transcripts of same gene, they
were suffixed with “_a”. If all probes were perfectly matched to multiple transcripts of
different genes, they were suffixed with “_s”. If probes were highly similar or identical to
other sequences, they were suffixed with “_x”. The probe sets with probes match to single
transcript were not suffixed.
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Figure 27: GeneChips® Human Genome U133 Plus-2 probe set marking (Figure adopted
from Design and Performance of the GeneChip® Human Genome U133 Plus 2.0 and
Human Genome U133A 2.0 Arrays technical note [61] )
3.2.2 Attaching Probes
Affymetrix® uses a photolithography technique to attach probes into spots. It is a
similar technique used for silicon computer chips where removal and positioning of silicon
material on the chip is controlled by selectively exposing light with the help of a mask.
Affymetrix® GeneChip® arrays photochemically modified synthetic linkers attached to
the array surface to block the nucleic acid addition until deprotected by a light. Ultraviolet
light is exposed to the array through the mask. Each mask is produced with windows that
direct the order of nucleotide addition by either transmitting or blocking the ultraviolet
light. When the mask has an open window at a specific spot, the spot gets deprotected and
becomes available for specific nucleotide addition (Fig 28).
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3.3 Data Files
3.3.1 Affymetrix GeneChip® Data Files
Affymetrix® GeneChip® technology uses special data formats to store GeneChip®
array information and the experimental results [62]. In this research, we obtained the
performed experimental results as CEL files and modify the original Chip Description Files
(CDFs) to create custom CDFs according to the current genomic data.

Figure 28: Affymetrix GeneChip microarray probe attaching via masked
photolithography (Figure adopted from Basic Concepts of Microarrays and Potential
Applications in Clinical Microbiology [59])
Some of the important files are:
a) EXP File: The EXP file contains information about experimental conditions and
protocols. It has three sections: sample information (chip type, sample type, operator),
fluidics (protocol, station, hybridization date), and scanner (pixel size, scanner type,
scan date).
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b) DAT File: The DAT file contains the pixel intensity values of the image produced by
the Affymetrix® scanner. It is a binary file and contains two sections: header and pixel
intensity data. It starts with header section and followed by pixel intensity data section.
Header has the dimension of the image (pixel number, coordinates of the grid, number
of rows etc.), the scanning conditions (temperature, scan speed, laser power, etc.) and
intensity related values (mean pixel value, minimum and maximum pixel value etc.)
The pixel intensity data has the intensity values of each row stored as 16-bit unsigned
integer values.

Figure 29: Part of the ASCII EXP file of chicken genome array supplied by Affymetrix®
in the Sample Data for GeneChip® Arrays
c) CEL File: The CEL file contains the calculated intensity values of each probe based
on the pixel intensities stored in a DAT file. It also provides the standard deviation of
intensities, the number of pixels used for the intensity calculation, an outlier flag and a
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user defined flag to indicate the spots that need to be left out during the analysis. It can
be either in ASCII text format (Version 3) or in binary format (version 4).
d) Chip Description Files (CDF): The CDF file stores the layout information for an
Affymetrix® GeneChip® array. Some of the important data described in CDF are:
which probes belong to which probe set, spot coordinates of each probe, name of probe
sets and PM-MM probe pairs (Fig. 31). It is used to read the intensity values of probe
sets located in the CEL file to detect the expression level of genes or transcript variants
of a gene. There are two versions of each CDF: an ASCII text format and XDA format.

Figure 30: Part of the ASCII CEL file of chicken genome array supplied by Affymetrix®
in the Sample Data for GeneChip® Arrays
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Figure 31: Part of the ASCII HG-U133_Plus_2.cdf file
e) The Gene Information (GIN) File: The GIN file contains genomic information of a
specific array such as the gene names associated with each probe set.

Figure 32: Part of the ASCII HG-U133_Plus_2.gin file
f) Probe Set Information (PSI) Files: Probe set names and the number of probe pairs in
a probe set. It uses ASCII text format. The first line of the file has the number of probe
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set names with “#Probe Sets” tag, the rest of the file contains the probe set names and
number of probe pairs in the probe set.

Figure 33: Part of the ASCII HG-U133_Plus_2.PSI file
3.3.2 FASTA File Format
FASTA format is used to describe nucleotide or peptide sequences in a text-based
file [63]. A sequence in FASTA format has two parts: single line description and sequence
data (Fig. 34). The description line starts with a greater-than (>) symbol. The word
following > is the identifier of the sequence, and the rest of the description line is optional.
The sequence data has the nucleotides or amino acids represented by single-letter codes.
Simple FASTA structure makes parsing easier for text-processing programs.
>probe:HG-U133_Plus_2:1007_s_at:718:317; Interrogation_Position=3330; Antisense;
CACCCAGCTGGTCCTGTGGATGGGA
>probe:HG-U133_Plus_2:1007_s_at:1105:483; Interrogation_Position=3443; Antisense;
GCCCCACTGGACAACACTGATTCCT
>probe:HG-U133_Plus_2:1007_s_at:584:901; Interrogation_Position=3512; Antisense;
TGGACCCCACTGGCTGAGAATCTGG
>probe:HG-U133_Plus_2:1007_s_at:192:205; Interrogation_Position=3563; Antisense;
AAATGTTTCCTTGTGCCTGCTCCTG
>probe:HG-U133_Plus_2:1007_s_at:844:979; Interrogation_Position=3570; Antisense;
TCCTTGTGCCTGCTCCTGTACTTGT

Figure 34: A part of the Affymetrix® GeneChip® HG-133 Plus 2 FASTA file
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3.3.3 General/Gene Transfer Format
General/Gene Transfer Format (GTF) is a tab-delimited text based file format
which is used to represent a gene structure information. GTF is an extended version of the
general feature format (GFF). It has additional columns specific to gene information. The
columns in a GTF are:
•

seqname : Name of the sequence usually chromosome, contig or scaffold id.

•

source : Name of a data source. It can be a program name, project name etc.

•

feature : Feature type name: Gene, transcript, exon, start_codon, stop_codon, CDS.

•

start : Start position of the feature.

•

end : End position of the feature.

•

score : A confidence degree in the feature existence and coordinates.

•

strand : Direction of the feature + is for forward, - is for reverse.

•

frame : 0, 1 or 2. 0 means that feature begins with whole codon, 1 means that before
the first whole codon, there is one extra base, 2 means that there are two extra bases
before the first whole codon.

•

attributes : Semicolon separated additional information about a feature.

•

comments : Comments begin with hash (#).
The following is an example gene structure with nine exons and two transcripts

taken from Ensembl gene annotation GTF file for human build 38.
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#!genome-build GRCh38
1 havana gene 11869 14409 . + . gene_id "ENSG00000223972";
1 havana transcript 11869 14409 . + . gene_id "ENSG00000223972"; gene_version "5"; transcript_id
"ENST00000456328";...
1 havana exon 11869 12227 . + . gene_id "ENSG00000223972"; gene_version "5"; transcript_id
"ENST00000456328";...
1 havana exon 12613 12721 . + . gene_id "ENSG00000223972"; gene_version "5"; transcript_id
"ENST00000456328";...; exon_id "ENSE00003582793";
1 havana exon 13221 14409 . + . gene_id "ENSG00000223972"; gene_version "5"; transcript_id
"ENST00000456328";...; exon_id "ENSE00002312635"; exon_version "1";
1 havana transcript 12010 13670 . + . gene_id "ENSG00000223972"; gene_version "5"; transcript_id
"ENST00000450305";...
1 havana exon 12010 12057 . + . gene_id "ENSG00000223972"; gene_version "5"; transcript_id
"ENST00000450305"; ...; exon_id "ENSE00001948541"; exon_version "1";
1 havana exon 12179 12227 . + . gene_id "ENSG00000223972"; gene_version "5"; transcript_id
"ENST00000450305"; ...; exon_id "ENSE00001671638"; exon_version "2";
1 havana exon 12613 12697 . + . gene_id "ENSG00000223972"; gene_version "5"; transcript_id
"ENST00000450305";...; exon_id "ENSE00001758273"; exon_version "2";
1 havana exon 12975 13052 . + . gene_id "ENSG00000223972"; gene_version "5"; transcript_id
"ENST00000450305";...; exon_id "ENSE00001799933"; exon_version "2";
1 havana exon 13221 13374 . + . gene_id "ENSG00000223972"; gene_version "5"; transcript_id
"ENST00000450305";...; exon_id "ENSE00001746346"; exon_version "2";
1 havana exon 13453 13670 . + . gene_id "ENSG00000223972"; gene_version "5"; transcript_id
"ENST00000450305";...; exon_id "ENSE00001863096"; exon_version "1";

Figure 35: A part of the Ensembl gene annotation GTF file for human build 38
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CHAPTER 4
CUSTOM CHIP DESCRIPTION FILES (CDF)
In Affymetrix® GeneChip® technologies, probe sets are formed from eleven to
twenty short oligonucleotide sequences called probes (see Section 3.2). After the
hybridization of specific samples is performed with an Affymetrix® GeneChip®, the
obtained intensity level of a probe set is interpreted as a gene expression level of the
specific gene. Therefore, more accurate selection of probes leads to more accurate
biological interpretation of experimental results.
Given a particular Affymetrix® GeneChip® platform, the design of the probes is
fixed. However, the methods in which the resulting experiments can be analyzed are
dynamic in nature due to the ability to annotate and group probes into uniquely defined
groupings. This is particularly important given that there are 97,015 data series publicly
available in the GEO [64] repository as of April, 2018. 4,873 data series sharing the exact
same chip design which is Affymetrix® GeneChip® Human Genome U133 Plus 2.0. Each
dataset consists of reassembled original submitter supplied records and curated data for
biologically comparable samples. One way in which the analysis can dynamically change
is by correcting the mapping between probe sets and genes by creating custom CDFs (Chip
Description File) to arrange which probes belong to which probe set based on the latest
genomic information or specific annotations of interest. Each analysis can improve the
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results of the microarray experiment or make them more relevant to annotations specific to
particular analysis.
This chapter mainly focuses on the issues of microarrays and previously suggested
solutions to address these issues.
4.1 Limitations of Microarrays
Since GeneChip® designs are by their nature fixed, the selection of probes relied
on earlier genome assemblies and annotation available at that time. Due to rapid progress
of genome sequencing and annotation, significant differences can arise between the earlier
and the current genome databases. The current databases are likely to be more accurate
than the earlier ones, contain more annotated coding and non-coding genes, and reveal
more information about alternative splicing of genes. Table 6 shows the original sequence
numbers of some source databases used for Human U133 Plus 2.0 Affymetrix®
GeneChip® at the time it was created and the latest ones. It is obvious there are significant
differences that should be taken into account, making it necessary to update probe-gene
mapping according to current databases. Affymetrix® does attempt to provide
compatibility between genomic chances by updating the links between probe sets and their
corresponding genes via NetAffxTM (http://www.affymetrix.com) [65]. NetAffxTM derives
the functional and descriptive annotations of representative sequence from current releases
of the UniGene [66], LocusLink [67] and Homologene [68] databases [69]. Representative
sequence stands for the sequence that was represented by a probe set in the array. When a
representative sequence could not be found in the databases, another representative
sequence is assigned to probe set based on the originally assigned UniGene [66] cluster.
But NetAffxTM does not provide a solution for problems caused by individual probes.
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TABLE 6: The release date and the number of human sequences for UniGene, dbEST,
Ensembl and RefSeq at the time of Affymetrix® HG-U133 design and the current versions
Original version
Release Date
Human Sequences
UniGene
dbEST
Ensembl
RefSeq

April 20, 2001(#133)
April 28, 2001
July 2001(#1)
April 2001

2.688.626
3.471.886
NA
12.716

Latest Version
Release Date
Human
Sequences
March 9, 2013(#236)
7,000,789
Jan 1, 2013(#130101)
8704,790
Apr 5, 2018(92)
3,609,003,417
Mar 13, 2018(87)
NA

Potential issues with probes in a probe set are:
I. Probes in a probe set that no longer align to a genomic location. In the HG-U133 Plus
2 array a total of 40,680 probes out of 603,158 (excluding quality control probes) do
not have a perfect match to the human genome assembly 38.
II. Probes in a probe set might not match any transcribed sequence or might be targeting
different genes than the designated gene of a probe set. Table 7 illustrates these two
types of problems. In the original Human U133 Plus 2 Affymetrix® GeneChip® probe
228543_AT has 22 probes, but only 11 of them match the RefSeq [70] entry
NM_001164811. The rest of the probes do not match any RefSeq location. Probe
228544_S_AT was originally created to measure expression level of the gene
CSRP2BP. But half of its probes map to the PET117 gene. Both CSRP2BP and PET117
are located in the chromosome 20 of forward strand and 5,051 bases of their sequence
overlaps. If one uses this probe to measure expression level of CSRP2BP, it could
reflect a cross hybridization with PET117. Probe 228543_AT has an even worse
situation. Only one probe matches to CSRP2BP, 11 of them match to PET117 and 10
of them do not match to any transcribed sequence. The expression level measured by
probe 228543_AT does not reflect the integrated expression of the designated gene and
therefore causes misinterpretation in quantification.
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III. Multiple probe sets often represent a gene. Often those probe sets might be coming
from the same splice variant or different splice variants. As long as probes were not
marked with an id specific to one splice variant, the expression level of probes cannot
be used as an indicator for the specific splice variant. In Table 7, both probe
225432_S_AT and 233396_S_AT match to CSRP2BP but at the transcript level; half
of their probes match to NR_028402 and rest of them match to NM_020536. The
measured expression level is inconsistent, and does not indicate which splice variant
changes in their expression level and is not as informative as the probe sets that matches
to a single splice variant.
IV. Different probe sets targeting different genes shares common probes. Such nonspecificity causes ambiguity and cross hybridization. In HG-U133 Plus 2 array total
36,493 probes out of 603,158 (excludes quality control probes) perfectly map to
multiple locations on the human genome assembly 38.
V. Some of the probe sequences contain single nucleotide polymorphisms (SNPs). SNPs
are the genetic variation between individuals of the same species [71]. A SNP
represents a base on a specific DNA location which differs between individuals. Most
complex diseases are associated with SNPs. For the accurate analysis of experimental
results, SNPS located within probes need to be detected and analyzed carefully. Some
researchers have paid attention to the effect of SNP presence in Affymetrix® probes.
Benovoy et at. [72] concluded that SNPs located in probes cause false-positives in
Affymetrix® Human Exon analyses and the position of a SNP within a probe sequence
effects the binding of targets to the probes. Rouchka et al. [3, 71] designed a
methodology to test the effect of SNPs that located in the 13th base of a probe sequence
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to hybridization rate of mismatch probes in Affymetrix® HG-U133A arrays. They
reported that less frequently, MM probes hybridization is greater than PM probes when
the target probe has a SNP in the mismatch location.
TABLE 7: The alignment of PM probes taken from HG 133 plus-2 array PM to RefSeq
database together with their corresponding gene symbol and the designated gene taken
from gin file. The alignments were achieved via Absolute Gene ID Conversion Tool [73]
Gene

RefSeq

PET117

NM_001164811
NR_028402
NM_020536

Designated
Gene
CSRP2BP

228544_S_AT
11
11

Probe Set
228543_AT 225432_S_AT
CRP2BP
11
1

11
11

233396_S_AT
11
11

4.2 Custom Designed CDF Files
Several researchers have called attention to probe-gene mapping problems [69, 7484]. To address these issues, they created their own CDF files in order to redesign probe
sets. These approaches have a similar work flow but differ in the data source used, the
selected target level (gene or transcript), whether to create probe sets from scratch or
redesigning the existing groups and sharing probes between probe sets. Table 8 gives a
summary of the previous work in the area of custom CDF construction. A few of them
offer public access to their custom CDF file.
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TABLE 8: Summary of available custom CDFs done by several researchers
Paper

Source Database
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Target Biomolecular
Entities

Number of Probes Per
Probe Set

Organisms

Available

Mapping Tool

Chalifa-Caspi et
al.

GenBank, Refseq, Ensembl,
GeneCards, UniGene

Gene

unknown

Human

No

BLAT

Laurent Gautier
et al.

RefSeq

Gene/Transcripts/ALU

unknown

Human

No

Bioconductor Package
matchprobes

Dai et al.

UniGene, RefSeq, DoTS, Entrez,
ENSEML, AceView...

Gene/
Transcripts/Exon

3

Human, Mouse, Rat,
Zebrafish, ...

Yes

unknown

Harbig et al.

GenBank

Transcript

unknown

Human

No

blastn

Liu et al

RefSeq, GenBank

Gene/Transcript

unknown

25 different Organisms

No

UCSC BLAT

Lu et al.

AceView

Transcript

4

Human

No

BLAT

Ferrari et al

GeneAnnot, GeneCards

Gene

6-11

Human

Yes

unknown

Yu et al.

GenBank, RefSeq, Ensembl,
IPI

Gene/Transcript

unknown

Human, Mouse, Rat, Bovine,
Zebrafish

No

Leeuw et al.

Entrez Gene

unknown

unknown

Human, Mouse

No

unknown

Ballester et al.

Ensembl

Transcript

NA

Human, Mouse, Rat, ...

Yes

Exonerate

Risueno et al.

ENSEMBL, RNAdb

Gene/Transcript/Exon/
ncRNA

unknown

Human, Mouse, Rat

Yes

blastn

Yin et al.

Ensembl, RefSeq, GenBank, Biomart,
ZFIN

Transcript

unknown

Zebrafish

No

Exonerate

BLAST

Chalifa-Caspi et al. [69] worked on updating the mapping of HG-U95 arrays via a
three step methodology without disbanding the original probe sets. First, they performed a
pairwise alignment between probe sequences and obtained transcripts from GenBank [85],
NCBI RefSeq [70] and Ensembl [86] via BLAT [87]. They assigned the probes to a
transcript when probes were in the mRNA orientation and had fewer than two mismatches.
If a probe did not match any transcript, they were then aligned to ESTs and their
representative EST accession number was stored. In the second step, the transcript was
mapped to GeneCard [88] genes or UniGene [66] clusters if a GeneCard gene was not
available. In order to convert UniGene results to GeneCard, they found corresponding
GeneCard genes of obtained LocusLink [67]/Ensembl [86] genes from UniGene [66]. If
the result did not have an annotated LocusLink gene, their corresponding genomic
locations obtained from UCSC [89] and used to create a link to a GeneCard entry via
GeneLoc. Obtained ESTs were mapped to UniGene cluster. In the last step, the transcript
and gene annotations were recorded and used to create probe set to GeneCard annotation.
If a probe matched to transcripts of a GeneCard gene, this probe was marked with this gene.
In addition to marking, they calculated a sensitivity score of the probe set by dividing the
number of major marked genes to the total number of probes and specify by finding how
many other genes maps to this probe set and with how many probes.
Laurent Gautier et al.[74] also worked on Affymetrix® Human GeneChip® HG133A and HG-U95Av2. They aligned PM and MM probes to NCBI’s human RefSeq
database [70] via a string matching Bioconductor package called matchprobes [90]. Only
PM alignments were accepted. They examined the probes that matched to multiple
reference locations in detail. They divided them into four analyzing groups. The first group
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included the probes that matched to the same gene’s different alternative splice variants.
They decided to keep them. The second group included the probes that matched to 300 to
600 different locations. When they study those probes, they discovered they were designed
to match human ALU repeats. ALU elements are highly repetitive short (around 280 to
300 base pairs) DNA sequences [91]. Rather than removing those probes, they put all of
them into one probe set and called it human ALU. The third group was for the probes that
matched to closely related annotations. Since separation of these genes requires expert
annotators, they simply ignored them. The last group contained the probes that matched to
multiple dissimilar annotations. They also removed them to prevent misleading analysis.
As a result of their study, they created open source software called altcdfenvs and made it
available to everybody as a Bioconductor package along with the data they used. However,
it is no longer publicly available.
The most effective (comprehensive) study for probe-annotation remapping was
achieved by Dai et al [75]. Rather than focusing on one reference database or combining
multiple ones to create one custom CDF, they worked on different databases and created
specific custom CDFs for each database. They proposed two different filtering and
regrouping frameworks; one for the UniGene database and one for RefSeq, Database of
Transcribed Sequences (DoTS)(http://www.cbil.upenn.edu/downloads/DoTS/), Entrez
gene [92], Ensembl [86] gene databases. According to their manuscript [93] some of the
UniGene cluster sequences are unreliable and the strand direction is unknown. In order to
get accurate UniGene based probe sets, special steps were required. First they started with
sequence alignments of probes and UniGene sequences.
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(I) UniGene sequences were aligned to the most recent genome assembly and genome
alignments were saved. This operation helped them to clean unreliable sequences in the
specific UniGene cluster.
(II) Individual probe sequences were aligned to the genome sequence.
•

Only perfectly matched probes were accepted. They also required each probe
to have one perfect match to the corresponding genome sequence. They
believed that the ones aligned to the non-transcript regions and one transcript
region could be kept but it is better to remove them for more reliable results.

(III) Individual probe sequences were aligned to UniGene and dbSNP to form new probe
sets.
•

A probe that is a perfect match to a genomic region also must align with
mRNA/EST sequences located in the UniGene database. The only exception
for this rule was exon-exon junction probes that had a perfect match to mRNA
sequence in the same UniGene cluster. They added them to the probe set with
the lowest index number.

•

Probes that matched with multiple cDNA/EST sequences of different UniGene
clusters were removed to make probes specific to only one UniGene cluster.
They believed that the probes in a gene specific probe set should include the
sequences that are common to all alternative splice variance of the gene so that
the results were not be affected by the tissue type. Because the knowledge of
alternative splicing genes was not complete, they decided to group all the probes
that aligned to the same gene to create a gene specific probe set.
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•

In addition to gene specific probe sets, they created transcript and exon specific
probe sets in order to study alternative splicing events. In addition, they created
probe sets that target the 3ꞌ end of probes.

•

If the targeted gene does not have a known mRNA/reference sequence, they
required that all the probes must be in the same direction on the genome. If the
probes in a probe set were perfectly matched to genomic regions in a different
direction and there is no mRNA/reference sequence in the UniGene cluster to
point out the transcription orientation, they divided them into two probe sets,
one for each direction.

•

They required all the probes, which represent one UniGene cluster, be aligned
continuously on the genomic sequence in the same direction except when
mRNA reference sequence of the targeted UniGene cluster aligns to the
different locations. If the probes spread across different genome locations or
chromosomes, the longest contiguous set of probes were used to represent the
UniGene cluster.

The well defined orientation and sequence information in the RefSeq, DoTS,
Entrez, and ENSEMBL databases let them to create new probe sets easier than the UniGene
database probe sets.
(I) First, they mapped the probe sequences to the corresponding genomic sequence and
target sequences. Only the probes that had one perfect match to the corresponding sequence
were accepted.
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(II) After alignment, they grouped the probes that mapped to the same target and had
correct orientation. They ordered the probes based on their location on the exon. Probe sets
that have fewer than three probes were removed. They created gene, transcript, exon and
3’ probe sets.
Besides updating probe sets based on the latest databases, they removed the perfect
match and mismatch probes that have an allele-specific base in the center of the sequence.
This was done to reduce the noise caused by single nucleotide polymorphisms (SNPs) in
different samples. These probe sets were called allele-independent.
For gene and transcript specific probe sets they paired database ids with GenBank
accession numbers in order to supply more stable ids for probe sets.
Harbig et al.[76] worked on alternative mapping of Affymetrix® HG-133 Plus 2.0
arrays. Unlike the others, they mapped the target sequences of probes that were obtained
from Affymetrix® rather than probe sequences. A target sequence is an exemplar region
of a specific transcript. It has ≤600 bases and was used to select short oligonucleotide
sequences (probes). Target sequences were mapped to GenBank records via blastn [94]
with a word size of 28. They saved the human RefSeq matched results (mRNAs); if there
were not any then they saved the matched human sequences (cDNAs). The sequences were
saved in the local database together with the original probe sets names and the calculated
score based on the type of sequence and alignment. Later the probe sequences were
compared with the collected sequences from the first step. The sequences were scored
based on how many bases of a probe in a probe set exactly matched to the sequence. The
best average score across all the probes was selected and assigned as a primary
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identification of the updated probe set. When the probe set had the same score for several
sequences identified, the researchers marked those probe sets as detecting multiple
transcripts. They kept the probe sets with low score values because they believed they also
contribute. In addition, they compared probes to the most common 8 human ALU
sequences and marked the ones matched to them. The probe sets with probes matched to a
completely different sequence from the rest of probes was evaluated manually. If the probe
set did not match to any sequence then it was compared to all GenBank sequences until a
match was found. Eventually they remapped 37% of the Hg133 plus 2.0 probe sets. The
website mentioned in the paper for methods and results are not available anymore.
Liu et al.[77] developed the AffyProbeMiner software to regroup probes and remap
probes to the targets for different organisms. They used RefSeq transcripts and validated
complete coding sequences in the GenBank as their target sequences. During the
construction of complete coding sequence database, they obtained the sequences that
included “complete CDS” and did not include “intronic transcript” or “BAC clone” in their
record. And also, they obtained RefSeq mRNAs whose accession number starts with
“NM_”. The obtained complete CDSs aligned to the genome, and the ones with less than
99% identity were removed from the database. After that, poly(A) tails were trimmed from
complete CDSs. As a last step of database creation, they removed one of the duplicated
records which was mapping to the same gene or one sequence covered by the other one
with less than or equal to 1% dissimilarity. The UCSC BLAT [87] server was used to map
probes sequences to created database. According to mapping results, they proposed four
different probe set grouping methods. They are transcript consistent (each probe in a probe
set maps to the same set of transcripts), transcript unique (each probe in a probe sets maps
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to the one transcript), gene consistent (each probe in a probe sets maps to the transcript of
the same set of genes) and gene unique (each probe in a probe sets maps to the transcript
of the one gene). They supplied CDFs of 25 different organisms for the R Bioconductor
environment, Affymetrix® GCOS and dChip. They claimed that providing a flexible tool
to create a CDF file and using the BLAT server and Perl (They provided faster process
than only using R) made their work better than others. Currently their tool, CDF files and
web site are not publicly available. Their method remapped the 65.6% of probe sets on
HG-U133A array.
Lu et al. [78] proposed a method that differs from others by the target database
used. They used the human transcript database AceView [95]. The AceView database was
formed from GenBank, dbEST and RefSeq mRNAs. Since it is a combined database, more
transcripts are covered than other databases thereupon mapping between probes and
mRNAs resulted with more matching. They matched a probe with a transcript when the
number of identical bases between them is more than 21 (out of 25 length probe sequence).
The probes with the same target(s) grouped together and composed one probe set. They
made sure that probe sets never share probes. To uncover the effects of the number of
probes per probe set over expression results, they created artificial data sets from the
Affymetrix® U133A Latin Square data [96] and ran simulations over them. Latin square
data is a test dataset provided by Affymetrix® to develop and compare analysis methods.
It is formatted as Latin square; nxn array of n different symbols in which each symbol
occurs only one in each row and in each column of the array. They analyzed the data with
the specially designed CDF which contains probe sets of randomly selected probes with a
variable number. i.e. for CDF d2, two random probes selected from each probe set.
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Simulation results clarified that when the number of probes in a probe set increase, the
reliability of expression measurements enhanced and the number of false positives
decreased. There is a prominent difference between the probe set size smaller than four and
bigger than three. Therefore, they only kept the probe sets with more than three probes.
The web site provided in the paper is not available anymore. With their proposed method
only 22% of original probes stayed without any change.
Ferrari et al. [79] worked on developing CDFs for Affymetrix® human arrays based
on the GeneAnnot [69] database. GeneAnnot contains the relationship between the
Affymetrix® probes and transcript sequences obtained from cDNAs, GenBank, RefSeq
and Ensembl. The probes were matched to obtained transcripts from previously mentioned
databases and then linked to GeneCards. Chalifa-Caspi et al. gave a more detailed
explanation of GeneAnnot construction methods already explained in this chapter. In
GeneAnnot, a gene was described with the HUGO gene nomenclature committee (HGNC)
database, Entrez Gene and Ensembl. All individual probes linked GeneCards gene reached
from GeneAnnot and the ones that linked to the same gene combined to create new probe
set. They created two CDF files; one had at least six probes per probe set and other one had
at least 11 probes per probe set. They analyze the same data with brain array CDFs,
AceView CDFs and their CDFs to compare the obtained differentially expressed genes.
They used robust multi-array average (RMA) [97] and significance analysis of microarrays
(SAM) [98] methods in R environment for analyzing. Most of the time around 40% of the
genes was commonly detected by all the CDFs. The highest similarity (on average 82%)
was obtained when their CDF’s results were compared with brain array [75] Entrez and
RefSeq

CDF

results.

Affymetrix®
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arrays

can

be

obtained

from

http://genecards.weizmann.ac.il/geneannot/customcdf.shtml. They also supply a search
engine to get specific information of a probe set and gene.
Yu et al. [80] were only interested in the probe sets that target the protein coding
transcript. For this reason in addition to GenBank, RefSeq and Ensembl, they used the IPI
(International Protein Index) [99] database to connect mapped mRNAs to external protein
accession numbers and get only the probes that target protein coding sequences. At first
they got the original probe set gene mapping information from the Affymetrix® NetAffxTM
[65] website. As mentioned in the paper their blast procedure based on the GeneAnnot
approach developed by Chalifa-Caspi et al. (summarized previously). Later they connected
the selected target mRNAs from blast filter to the protein IDs in IPI database. Connected
protein IDs were used to create new probe sets. As a result some of the probes classified to
four groups; transcript unique (all the probes mapped to one protein), gene unique (all the
probes mapped to alternative spliced proteins of same gene) cross-hybridize (maps to
proteins of multiple genes) and not categorized (not connected to any protein). The probes
that did not map to any protein were eliminated. When the probe matched to multiple
variants of the same gene they annotated it with gene level annotation. When probe
matched to the single variant of a gene they annotated the probe in transcript level. At the
end they covered the 85.4% of original Affymetrix® target genes and 68.8% probes were
kept in the new CDF file.
Leeuw et al. [81] believed that probes removed during custom CDF creation might
be important for researchers to study not yet well established genes and proposed a method
called CDF-Merger. CDF-Merger aims to regain the lost information due to removed
probes by creating Hybrid CDFs from Affymetrix® CDF, Affymetrix® annotation files,
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Brainarray custom CDFs and NCBI Entrez Gene Info Files. First they customized the
Affymetrix® CDF and Brainarray CDF. The rules of customizing Brainarray CDF are: (I)
Redefine the probe-set ids (atd_Entrez) to be able to track (II) Put “_d” to the probe set
name when probe set has probes that is shared with other probe sets. The rules of
customizing Affymetrix® CDF are: (I) Keep the original Affymetrix® probe set names for
tracking. (II) Discard the probe sets that contained more than two probes which was already
used in Brainarray CDF. (III) If a probe set shares one or two probes with Brainarray probes
then remove the probes from probe set and keep the rest the probes, add _1 or _2 to the
probe set name. (IV) Check the Affymetrix® annotation file with NCBI Entrez GeneInfo.
If a probe set can be annotated by more than one Entrez id then leave annotations of these
probe sets empty. (V) Remove the annotations of probe sets already targeted in the
Brainarray CDF. (VI) Rename all the probe set names with pattern “atm_Entrez_id”. (VII)
Unite the probe sets that share the same Entrez id and mark them by putting _m to their
name. After customization they combined the all probe sets into one CDF and created R
environment CDF.
Ballester et al. [82] performed annotations for multiple organisms. They started
updating by mapping PM probes to the corresponding genome via the exonerate alignment
tool [100]. They discarded the probes that aligned to genome with more than one mismatch
and probes that aligned to more than a hundred times on the genome. Later on they mapped
probe sets to the Ensembl transcripts. If at least half of the probes in a probe set mapped to
a specific transcript then they annotated the probe set with this transcript. The results can
be reached from the Ensembl web site. From the BioMart search tool [101], one can get all
the annotations for a specific array. In addition to web access, BioMart can be also accessed
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via the R programming language with the Bioconductor package biomaRt. They also have
a perl API to let users reach the data. The annotated GeneArrays are arrays are from
Affymetrix®, Illumina and CodeLink.
Risueno et al. [83] worked on updating probe mappings of Affymetrix® human,
mouse and rat microarrays and shared the results, files and created tools from a web site
called GATExplorer (Genomic and Transcriptomic Explorer). As in other studies they
mapped the probe sequences to the target database and annotated them according to the
mapping results. Mapping was performed with blastn. Target sequences of mRNAs and
cDNAs were obtained from Ensembl. Only PMs were accepted. Different than other
approaches, they mapped probes that were not mapped to the coding regions to the noncoding RNA (ncRNA) and created CDFs from the mapping results. They used Ensembl
and RNAdb [102] as a source for ncRNAs. The CDFs are classified into four groups:
probes to gene loci, to transcripts, to exon and to ncRNA. They can be downloaded as an
R library. They supply txt files that show the mapping of probes to gene loci and transcripts
with Ensembl id, gene name and symbol. One can search a specific gene and examine it
with the visualization of loci, transcripts, exons and mapped probes on a chromosome.
They also give a presentation of gene expression patterns obtained from GeneAtlas [62]
based on probe sets for a specific gene. In addition to gene based search, probe set, genome
coordinate, sequence of nucleotide and amino acids based searches can be performed from
the web site.
Yin et al [84] adopt the Dai et al.’s proposed method with some main changes to
remap Affymetrix® zebrafish genome arrays. To determine genome specific probes, first
they mapped the probe sequences to genome version 7 via Exonerate. They removed the
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probes that did not match the genome and transcripts or matched to multiple locations. To
be able to detect cross exon boundaries, they kept the probes that had no matching to
genome but matched the transcript. Later the probes were aligned to transcripts that were
composed from Ensembl, RefSeq, GenBank, Biomart, and ZFIN [103]. They downloaded
the transcriptome alignment coordinates and coding sequence coordinates from the UCSC
genome browser and followed the procedure Exlink [104], proposed by the Ensembl group,
to organize transcripts of different databases. The idea behind Exlink is clustering the
transcripts under same gene when their coding regions are overlapped. During the mapping
process, the probes that mapped to multiple genes, intergenic regions or introns of genes
were removed. The probes that passed the filtering step were clustered based on the
transcripts they mapped. One specific cluster was either representative of a transcript or
multiple common transcripts of the same gene. Since the reverse complementary probes
generates weaker signal than positive strand probes, they were grouped separately from
positive strand probes. They also wanted to pay attention to the effect of the selected
database over probe remapping by performing an experiment. They examined the one
specific data set with probe mapping created based on Ensembl and probe mapping created
based on a multiple source database, UCSC. The differently expressed genes detected by
multiple databases were more comprehensive than Ensembl and the multiple source
database was also able to detect more alternative splicing events than Ensembl. To
strengthen their conclusion they performed real time PCR validation for a select number
of genes. Only UCSC were able to detect PCR validated genes.
In our work we also redefine the mapping between probe sets and target genes by
creating custom CDFs (Chip Description File) based on the latest genomic information. In
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contrast to previous approaches we annotated probes in UTR and individual exon levels in
addition to gene and transcript levels. Furthermore, we used interval alignment via Nested
Containment List (NCList) rather than sequence alignment. We also provide flexibility for
users to create custom CDFs for their specific annotations of interest.
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CHAPTER 5
COORDINATE MAPPING BETWEEN PROBES AND ANNOTATIONS
Mapping between sequences, genomes and genome annotations is one of the main
process of bioinformatics related works. For example, assembly of multiple sequences is
used to construct the complete genome of an organism. Mapping between a query sequence
and specific regions of an organism genome is used to identify annotations of the query
sequence. Mapping used for comparative genomics query deals with finding common
annotations between different genomes.
In bioinformatics, biological annotations in a genome such as genes, transcripts,
UTRs, exons, introns and SNPs are modeled as intervals. For example, the human gene
GRIK4 is located on the chromosome 11 of human genome assembly 38, starts at
120,511,700 and ends at 120,988,904. It has twenty-one exons. One of exons whose
Ensembl id is ENSE00003810695, starts at 120,511,887 and ends at 120,511,887.
Therefore, finding annotation of a query sequence requires coordinate mapping. In our
research, we used coordinate mapping to update mapping between probes and target genes
by searching coordinates of a probe against coordinates of a genome.
Several structures have been applied to interval overlap searches in genomics. A
BTree (MySQL database) with binning method has been used by the UCSC genome
Browser [89]. The binning method partitions data into hierarchical bins and search the
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intervals only in the matching bins. But it is not efficient for counting overlaps because all
candidate bins need to be searched to find possible overlaps. R-tree indexing can also be
applied for interval overlap searching. One of the variation of the general R-tree is interval
trees. Interval trees are used by composing the tree from genomic coordinates of genes and
searching coordinates of probes in the tree. Another faster and widely used way of
performing interval overlap search is creating interval database representation of genomic
coordinates via nested containment list (NCList) and searching probe coordinates in the
NCList database. In our research, since the probes within a probe sets are short nucleic acid
sequences, their genomic coordinates are not defined. We used the Bowtie alignment tool
to obtain the genomic coordinates of probe sequences. It was also used to detect nonspecific
probes. After obtaining probe coordinates, we used Nested Containment List (NCList) to
perform mapping between probes and genomic annotations.
5.1 Bowtie
Bowtie (http://bowtie-bio.sourceforge.net/index.shtml) is a tool for aligning short
read sequences to the large genomes [53]. It is fast and memory efficient. There are two
main versions: bowtie 1 and bowtie 2. Bowtie 1 allows alignment of short reads to long
reference genomes (e.g. mammalian). Bowtie 2 allows alignment of relatively long reads
(100s of characters) to long reference genomes. It provides gapped, local and paired-end
alignment modes.
Bowtie’s reference genome is indexed with a Burrows-Wheeler transform so that
its memory footprint becomes small. It uses an extended version of exact mapping called
inexact matching to align short reads to an indexed genome. Backtracking and double
indexing are two major extensions. It allows mismatches with high quality alignments
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through the quality aware backtracking. Bowtie avoids excessive backtracking via double
indexing.
In our work we used bowtie version 1.0.1 to align short probe sequences to the
genome thereby the probes that no longer align to a genomic location or perfectly align to
multiple genomic locations are removed and cross-hybridization effects are reduced. The
following sections describe the algorithms used by Bowtie.
5.1.1 Burrows-Wheeler Transform
Burrows-Wheeler transform (BWT) is an algorithm developed for efficient data
compression (Fig 36). It takes a character string and rearranges it. The result of the
transformation contains the exact same characters that were started with, differing only in
their ordering. It is useful for compression because it orders repeated characters next to
each other and makes the data more compressible by algorithms such as run-length
encoding [105]. Because it allows large texts to be searched efficiently with a small
memory requirement, it is applied to sequence alignment in bioinformatics. The
transformation is reversible.

Figure 36: A Burrows-Wheeler transform (BWT)
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Without any additional data, BWT of a character string supplies information for:
•

The number of occurrences of a specific character in the text.
Since the BWT(T) is the permutation of the original text, we can count the number of
occurrences of a character in the BWT(T).

•

Reconstructing the first column of the matrix M.
BWT(T) has all the characters in the text. Sorting the BWT(T) lexicographically will
return the first column of the matrix M.

•

Whether a specific two characters length substring is present or not in the original text.
The first property of Last-First (LF) Mapping formulated by Ferragina and Manzini
[106] is used to search for a substring. BWT(T) is ordered lexicographically and the
rows that has the first character of the substring are used as index to look for the second
character of the substring in the BWT(T). If at least one of the marked rows has the
second character then we can say that the original text has the substring.

•

The second column of the matrix M.
It can be recovered by Last-First (LF) Mapping. From the last and the first columns,
we can get the set of two consecutive characters in the original text. Since each row of
the matrix M is cyclic shift, the same consecutive characters must be occurred between
the first and the second column also. Based on this property, we can fill the second
column. The same property is also used to recover the rest of the matrix M.

5.1.2 Inexact Matching
To map reads to the genome one must consider sequencing errors, mismatches, and
genuine differences between the reference and query. But the exact matching does not
handle these conditions. To make exact matching appropriate for genome mapping, bowtie
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developed an algorithm called inexact matching. It uses backtracking to find alignments
that satisfy the alignment policy which “allows a limited number of mismatches and prefers
alignments where the sum of the quality values at all mismatched positions is low” [53].
The procedure of inexact matching is similar to the exact matching unless range
does not become empty. When the range becomes empty, the algorithm might replace
already matched query position by another base to allow mismatches between the reference
and the query and then search resumes after the mismatch position. To substitute a base, it
has to be consistent with the alignment policy and modified query has to be present in the
text. When there are multiple candidates for substitution position, the position with a
maximal quality is selected.
Backtracking was implemented via a stack data structure. The stack structure grows
when a substation candidate selected and shrinks when the substation candidate is rejected.
The alignment found via Bowtie might not be the best possible alignment in terms of
number of mismatches and quality but the tool allows user to select best option to find the
best possible alignment in terms of the number of mismatches. But it comes with a time
cost.
5.1.3 Double Indexing
When more than one mismatch is allowed, a search might be too slow because of
excessive backtracking. To avoid this, bowtie introduced a new technique called double
indexing. Bowtie indexes both the genome (forward index) and reverse (character reverse)
of the genome (mirror index). Searching the mirror index with reversed query is the same
with normal search that progress left-to-right instead of right-to-left.
79

Figure 37: Exact matching versus inexact alignment. (figure adapted from [53] under
Creative Commons Attribution Non-Commercial License)
5.2 Interval
An interval is a value pair of real numbers [a,b] such that a ≤ b. It represents the set
{x є R : a ≤ x ≤ b}. a and b called the endpoints of the interval. The endpoints can be
included or excluded from the set.
•

When both endpoints are excluded from the set, it is called an open interval. They
are represented as:
(a,b) = ]a,b[ = {x є R | a < x < b}

•

When one endpoint is included in the set, it is called a half-open interval. They are
represented as:
[a,b) = [a,b[ = {x є R | a ≤ x < b} OR (a,b] = ]a,b] = {x є R | a < x ≤ b}
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•

When both endpoints are included in the set, it is called a closed interval. They are
represented as:
[a,b] = [a,b] = {x є R | a ≤ x ≤ b}

Between two intervals x and y, there can be three different relations.
•

x and y overlap when low(x) ≤ high(y) and low(y) ≤ high(x).

•

x is to the left of y when high(x) ≤ low(y).

•

x is to the right of y when high(y) ≤ low(x).

5.3 Interval Tree
An interval tree is an augmented red-black tree [107]. It provides efficient access
to set of intervals (Fig. 38).
A red black tree is a binary search tree with extra color information. The color makes
the tree approximately balanced by controlling the node coloring for every path from a
given node to any of its leaf. A red-black tree must satisfy the following properties:
1. “Every node is either red or black.
2. The root is black.
3. Every leaf (NIL) is black.
4. If a node is red, then both its children are black.
5. For each node, all paths from the node to descendant leaves contain the same
number of black nodes.” [107]
Every node in an interval tree contains extra two fields; an interval defined by low
and high value pair and the maximum value stored in the subtree of the node.
max[x] = max(high[x], max[left[x]l, max [right [x]])
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In our examples the intervals are closed. An interval tree is ordered by low values
of each interval. Thus, the in-order traverse returns the intervals ordered by low borders. It
allows insertion, deletion, and search operations. Since an interval tree is a red black tree
and height of the red black tree is smaller or equal to 2lg(n+1) (n is the number of nodes
(intervals) in the tree), the worst case running time for all three operations is O(log(n)).

(a)

(b)
Figure 38: An interval tree example. (a) A set of intervals (b) The interval tree
constructed from the set of intervals
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5.3.1 Interval Tree Operations
•

Search
A search operation takes an interval such as [low(x), high(x)] and looks for

overlapping intervals in the tree.
Fig. 39 shows the pseudo code of interval tree search taken from Cormen et al.
[107]. The function takes interval tree T and interval i. It either returns the interval that
overlaps to i or the sentinel nil[T]. The search starts from the root, continues downward
through the three and terminates when overlapped interval found or x points to the sentinel
nil[T].
INTERVAL-SEARCH(T, i)
1 x  root(T)
2 while x ≠ nil(T) and i does not overlap int[x]
3 do if left[x] ≠ nil[T] and max[left[x]] ≥ low[i]
4
then x  left[x]
5
else x  right[x]
6 return x
Figure 39: Interval tree search pseudo code
•

Insert
The insert operation takes the root of the interval tree and the interval as an input.

It searches for proper position based on the intervals low end and inserts the interval via
updating left, right and root pointers of the affected nodes. After insertion, the interval tree
fix up function is called to ensure that red-black tree properties are still satisfied.
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•

Delete
The delete operation is similar to insert. It takes the root of the interval tree and an

interval as an input. It searches for proper position based on the intervals low end. Along
the way the max field of nodes and balance factors are updated.
5.4 Nested Containment Lists
Nested Containment List (NCList), interval database representation, was developed by
Alexander V. Alekseyenko et al. [108] to overcome the difficulties of finding overlapping
sequence intervals in exponentially growing sequence databases.
Typically time complexity of finding the first overlapping interval to a query is O(log
N) in a database composed of N intervals. But in most cases, interval search requires
finding all overlapping intervals. Since intervals are not guaranteed to be contiguous on
both start and end coordinates, a search cannot end when the first overlapping interval is
found. For example, Fig. 40 demonstrates querying in two databases. In Fig. 42a intervals
are ascending ordered based on interval start coordinates. In this type of structure,
overlapping intervals might be spread all over the structure. Thus, on average half of the
structure needs to be searched to find all overlapping intervals.
If one looks carefully at the start coordinate ascending ordered interval list, it can be
seen that intervals contained within another interval prevent them from being sorted based
on both start and end coordinates. This problem can be solved by removing contained
intervals because if an ascending ordered list of intervals does not have contained intervals,
it will be also sorted based on end coordinates. Thus, when the first non-overlapping
interval is found, the search can be halted.
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Figure 40: Difference between start coordinate sorted database and a NCList data
structure. Intervals shown in bold are overlapping intervals with the query interval (figure
adapted from [108] under Creative Commons Attribution Non-Commercial License)
Alexander V. Alekseyenko et al. created NCList to partition the intervals into
subsists so that in each partition no interval is contained by another interval. For example,
in Fig. 42b the first sub-list contains an ascending ordered list of 7 intervals. Additional
sub-list intervals that fully overlap with an interval in the predecessor sub-list are shown in
a separate box. As seen from the Fig 41b, detected overlapping intervals (shown in black)
are located back to back in each of the sub-list. Since the NCList structure guarantees that
a sub-list contains only non-overlapping intervals, after a non-overlapping interval to a
query interval is found, the search can be halted. In this way the time complexity of finding
all overlapping intervals to a query interval is reduced to O (log N + n). N represents the
number of intervals contained in the database of intervals and n represents the number of
overlapping intervals to the query interval.
5.4.1 NCList Data Structure
An NCList structure is composed of two arrays; the sub-list headers array (H) and
the interval array (L) (Fig 41). The sub-lists headers array (H) stores the record index of
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first element and its length for each sub-list Sx. The interval array L stores the sub-lists
indexed in H.

Figure 41: “Schematic representation of NCList data structure. Here in the
interval array L, element L[i] has non-empty sublist, which records is indexed in sublist
header array H by L[i]. SUBLIST. This sublist starts at START and has length LENGTH.
L[i] itself belongs to the top level list S0, which has sublist header H[0]” (figure adapted
from [108] under Creative Commons Attribution Non-Commercial License)
5.4.2 Query of overlapping intervals
Query of overlapping intervals composed of recursive 3 main steps:
1) Binary search in a sub-list Sx.
2) Scan in the sub-list to return overlapping intervals that has a sub-list.
3) Execute same procedures recursively over the intervals that has a sub-list (Fig
42).
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Figure 42: NCList overlap query pseudo code [108]
The time complexity of this algorithm is O(log(N/α) + n). N is the size of the
intervals database, α is the average number of intervals contained in any top-level interval
and n is the number of overlapped intervals for a given query interval.
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CHAPTER 6
METHODS
We developed an Affymetrix® GeneChip® probe remapping protocol at the level
of genes, transcripts, untranslated regions (UTRs) and individual exons based on the
genome and Ensembl annotations. The protocol takes annotations in a General/Gene
Transfer Format (GTF) file (see Section 3.3.3), generates a Custom Chip Description File
(CDF) where probes are grouped into probe sets based on region (UTR, individual exon),
transcript or gene level. Here, we define individual exons as coding exons within protein
coding genes, or all exons within structural RNAs (such as miRNA and lncRNA). In effect,
the individual exons refer to all non-UTR portions of exons. The region based grouping is
beneficial to profile the contribution of UTR, and exon regions to the gene expression
levels globally as well as their independent differential expression which may play a
significant biological role. The gene and transcript based CDFs allow obtaining gene
expression levels of interest based on the latest genomic information. Since annotations
rely on the input file provided by the user, it gives researchers the opportunity for analysis
based on a specific set of annotations.
6.1 Steps for Generating Custom CDFs
Custom CDF generation is composed of three main steps: mapping probes to the
genome, annotation of probes, and assignment of probes to probe sets based on annotations.
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Fig. 43 shows the flow chart of annotation and grouping of probes based on the
region of a gene. After the probe sequences are mapped to the latest assembled genomic
DNA sequences via Bowtie [53] version 1.0.1, the probes were annotated based on the
overlapping between probes and gene structures taken from the GTF file using NCList.
Probes that share the same annotation were grouped into one probe set. Annotations vary
according to the type of CDF file. For region level custom CDFs, probes were mapped to
the 5ꞌ and 3ꞌ UTR, and individual exon start and end locations of every gene and probe sets
were named according to the gene id and region. For the gene level custom CDFs, probes
were mapped to the start and end locations of every gene and probe sets were named
according to gene id. For transcript level custom CDFs, probes were mapped to the start
and end locations of every transcript and probe sets named according to transcript id. In
every step different filtering criteria are applied for each CDF file.
6.1.1 Mapping of Perfect Match Probes to a Genome
PM probe sequences, which can be obtained from the Affymetrix®
Netaffx™ analysis center web site or GEO in a FASTA file format, are aligned to the
indexed genome using Bowtie version 1.0.1 with the parameters -v 0 and –m 1, requiring
that probes align to a single genomic location with 100% identity, thereby the probes that
no longer align to a genomic location or perfectly align to multiple genomic locations are
removed and cross-hybridization effects are reduced. Note that Bowtie version 1 is best at
aligning shorter sequences (25-50 bp) as found with microarray probes while the most
recent versions of Bowtie are optimized for long sequence reads (>50 bp). Mismatch (MM)
probes are not considered in the mapping step, although they could theoretically map
uniquely to genomic regions. Rather, the MM probes are set aside and are included with
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their corresponding PM probe during the final CDF construction step once the PM probes
have been assigned to a probe set. During this analysis, only probes perfectly matching to
a region are considered. Therefore, probes crossing splice junctions will be discarded. The
following is a line taken from the alignment results of Affymetrix® HG-133 Plus 2 to the
HG38 genome index.
probe:HG-U133_Plus_2:1053_at:987:1005; Interrogation_Position=1216; Antisense;

-

7 74232149

Figure 43: Flow chart for region-based probe annotation framework
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Until the end of the last semicolon, the line includes the information taken from the
Affymetrix® HG-133 Plus 2 probes FASTA file. The rest of the line shows that the probe
was aligned to the antisense strand (- for antisense, + for sense strand) on chromosome
seven starting at base 74,232,149.
6.1.2 Annotation of Perfect Match Probes via NCList
Probes were annotated based on the overlap between probes and genomic intervals
by the following steps.
I.

General/Gene Transfer Format (GTF) files for the studied species were obtained from
the Ensembl [86] ftp server. Each GTF is a tab-delimited text file used to represent
gene structure information, including the start and end positions of a gene together with
chromosome location. Each structure is tagged with a feature which can be gene,
transcript, exon, start_codon, stop_codon, CDS or UTR. Fig. 44 shows structure tags
marked

with

red

lines

for

the

FO538757.2

gene

located

in

the

Homo_sapiens.GRCh38.85.gtf. It has one transcript that composed of three exons. It
also has CDS, start_codon, stop_codon and five_prime_utr together with the start and
end positions. Ensembl GTFs were used since the annotations are determined by an
automated system based on experimentally verified data combined from multiple
databases such as RefSeq, EMBL and UniProtKB. It also contains manual curation for
selected species.
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Figure 44: Features of the FO538757.2 gene in GTF
II.

A nested containment list (NCList) index was created for each chromosome from
intervals (start and end points) of gene structures. The intervals of the NCList were
selected based on the target of the probe sets. When the probe sets were constructed
based on gene or regions of a gene, we used UTR and individual exon intervals. For
transcript targeted probe sets, we used transcript intervals.

III.

Probe intervals were searched in the NCList indexing and annotated according to the
overlapping results. Probes were split based on the matched chromosome. Each probe
group interval was searched in the same chromosome’s NCList indexing. When an
overlap was found, the probe was annotated with the list node. Only complete overlaps
were accepted; both the low and high ends of the interval must be included in the list
node. The probes which did not overlap the nodes were discarded. As a result, probes
partially overlapping UTRs, and individual exons will not be included at the region and
gene level, but will be present at the transcript level. Table 9 shows the annotations for
the Affymetrix® HG-133 Plus 2 probes which were located on chromosome six and
searched in the NCList indexing.
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TABLE 9: Probe annotation outputs at the end of NCList indexing search
Probe
223120_at:528:909
223120_at:861:491
223120_at:683:349
223120_at:949:165
223120_at:585:237
223120_at:605:739
223120_at:605:739
223120_at:543:383
223120_at:543:383

Start
143501994
143501942
143497416
143495814
143495755
143495514
143495514
143495501
143495501

End
143502018
143501966
143497440
143495838
143495779
143495538
143495538
143495525
143495525

Annotation
ENSG00000001036_exon
ENSG00000001036_exon
ENSG00000001036_exon
ENSG00000001036_exon
ENSG00000001036_exon
ENSG00000001036_exon
ENSG00000001036_UTR
ENSG00000001036_exon
ENSG00000001036_UTR

The following are pseudocode snippets for generating CDFs.
Region Based CDF
Get probe intervals and chromosome locations from the text file
Get intervals of individual exons and UTR for each gene from gtf file
Split intervals based on chromosome location
For each chromosome chr {
Split intervals based on gene region (exon, UTR)
For each gene {
For each region
Combine overlapping intervals
}
Create NCList indexing of intervals belong to the chr
For each probe located on chr
Search probe interval in the NCList indexing
Annotate probe with region intersecting gene
}
Create probe sets
Write probe sets into ASCII CDF files
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Transcript Based CDF
Get probe intervals and chromosome locations from the text file
Get intervals of transcripts for each gene from gtf file
Split intervals based on chromosome location
For each chromosome chr {
Create NCList indexing of intervals belong to the chr
For each probe in chr
Search probe interval in the NCList indexing
Annotate probe with intersected transcript
}
Create probe sets
Write probe sets into ASCII CDF files

Gene Based CDF
Get probe intervals and chromosome locations from the text file
Get intervals of individual exons and UTR for each gene from gtf file
Split intervals based on chromosome location
For each chromosome chr {
Split intervals based on gene region (exon, UTR)
For each gene {
For each region
Combine overlapping intervals
}
Create NCList indexing of intervals belong to the chr
For each probe located on chr
Search probe interval in the NCList indexing
Annotate probe with intersected gene of the region
}
Create probe sets
Write probe sets into ASCII CDF files
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IV.

A probe’s start and end points may overlap multiple genomic structures. It may overlap
with the UTR and individual exon region of the same gene (as seen in table 9) or with
multiple genes or transcripts. To remove cross hybridization and ensure probes
uniquely map to a single region, gene or transcript, we choose one of the annotations
for each probe and remove the remaining matches. The rule for assigning these probes
occurs with the following priority (I) 5′ and 3′ UTRs; (II) individual exons. Thus,
although UTR regions technically occur within exons, the more specific UTR
assignment will be used. When the annotation was based on gene or transcript the first
obtained annotation was selected.
In the previous example, probe 223120_at:543:383 overlaps both the exon and UTR
region of the FUCA2 (ENSG00000001036) gene (Table 9). During filtering, matching
between the probe and the exon will be removed because our first preference is UTRs
(preference order 5ꞌ UTR - 3ꞌ UTR – individual exon). Because of preference in the
CDF the probe will be only used to represent the UTR region of the FUCA2 gene.

V.

Probes with the same annotation were grouped together to form a probe set.
For example, in the previous example, 223120_at:528:909, 223120_at:861:491,
223120_at:683:349, 223120_at:949:165, 223120_at:585:237 will form a probe set to
represent the individual exon region of the FUCA2 gene. Fig. 45 shows the grouping
of probes for three types of CDFs. These CDFs are:
o Region-based CDF: Probe sets are designed to target a specific region of a gene
and consist of probes which map to the same region (UTR, individual exon) of
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a gene. In Fig. 45, green probes were mapped to the UTR region of Gene_1;
therefore, those probes cluster together to form the Gene_1 UTR region probe
set. Based on the same logic, blue colored probes form the probe set for Gene_1
exon.
o Gene-based CDF: Probe sets are designed to target genes and consist of probes
which map to the same gene. In Fig. 45, green and blue colored probes, which
mapped to Gene_1, cluster together to form the Gene_1 probe set.
o Transcript-based CDF: Probes that map to same transcript of a gene compose a
probe set. In Fig. 45, the orange and red arrow show the start and end positions
of Transcript_1 and Transcript_2. The probes mapped to the Transcript_1 (two
greens, five blues) cluster together to form the probe set for Transcript_1.

Figure 45: Creating probe sets for different types of custom CDF based on probe
mapping to genomic structures
VI.

Probe sets were saved into ASCII format CDF files. In addition to the probes specific
for a particular gene, Affymetrix® GeneChips® contain a number of different control
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probes such as probes that are added during sample preparation, providing evidence
that assay was performed properly. We added those probe sets to our CDFs without
any change.
6.1.3 Probe Set Naming
Since GTF files obtained from Ensembl were used, Ensembl gene ids were
employed to distinguish different genes and Ensembl transcript ids were used to distinguish
different transcripts. When the generated CDF was based on regions of genes, the region
was suffixed to the Ensembl gene id. Strand direction specified in the GTF of the genomic
structure is also suffixed (- or +). Table 10 shows example probe set names taken from
custom CDFs for the Affymetrix® GeneChip® HG-133 Plus 2.
TABLE 10: Custom CDF naming examples
CDF Type
Region-based
Gene-based
Transcript-based

Probe Set Name
ENSG00000001036_EXON_ENSG00000001631_THREE_PRIME_UTR_ENSG00000001461_+
ENST00000489806_+
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CHAPTER 7
affyCustomCdf: AN R PACKAGE FOR CREATING CUSTOM CDF
We developed an R package, affyCustomCdf, for allowing users to create custom
CDFs via removing nonspecific probes, updating probe target mapping based on the
supplied genome information and grouping probes into region (individual exon, UTR),
gene and transcript levels. It has been implemented in R and C++ languages based on the
Bioconductor

package

requirements

and

publicly

available

at

https://github.com/UofLBioinformatics/affyCustomCDF.
7.1 affyCustomCdf Tool
To create a custom CDF via affyCustomCdf tool, one must call the
createAffyCustomCdf function after installation of the tool. The createAffyCustomCdf
function produces a custom CDF based on parameters this includes the original CDF, probe
alignment file and annotation (GTF) file which must be supplied by the user. The remaining
parameters are optional, with a default value set (for more details see appendix). Fig. 46
describes the parameter selection for creating a custom CDF via the affyCustomCdf tool.
7.1.1 Custom CDF Types
The affyCustomCdf tool can produce main three types of custom CDF. They are
region-based, gene-based and transcript based.
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•

Region based CDF: In region based custom CDFs, probe sets consist of probes
which map to the same region (individual exon, UTR) of a gene. It can be obtained
via supplying “regionG” value to the type parameter of the createAffyCustomCdf
function.

•

Gene based CDF: In gene based custom CDFs, probe sets consist of probes which
map to the same gene. It can be obtained via supplying “gene” value to the type
parameter of the createAffyCustomCdf function.

•

Transcript based CDF: In transcript based custom CDFs, probe sets consist of
probes which map to the same transcript of a gene. It can be obtained via supplying
“transcript” value to the type parameter of the createAffyCustomCdf function.

In addition to main three types supplied above, files can be diversified via defining
rules for probe selection and directional relationship between probes and annotations.
Three different types of custom CDF can be produced based on the sense/antisense
relationship between probes and annotations. They are no direction, same direction and
opposite direction.
•

No direction CDF: When no direction rule is applied, direction will not be
considered during probes to annotations mapping. This can be performed via
supplying “0” value to the SD parameter of the createAffyCustomCdf function.

•

Same direction CDF: When same direction rule is applied, mapping is performed
between same directions such as sense probes can only map to sense annotations.
This can be performed via supplying “1” value to the SD parameter of the
createAffyCustomCdf function.
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•

Opposite direction CDF: When opposite direction rule is applied, mapping is
performed between opposite directions such as sense probes can only map to
antisense annotations. This can be performed via supplying a value except 0 or 1 to
the SD parameter of the createAffyCustomCdf function.

Probe selection can be defined in two ways. Allowing probe share between transcripts
of a gene or removing a probe according to the number of matched annotations to the
probe.
•

Use probes map to one annotation: When unique probe option is selected, probes
that maps to more than one annotation are discarded from a region-based CDF. This
option is provided to allow users to examine unique probes to one specific
annotation. It can only be used with the regionG type. Selection can be supplied to
the createAffyCustomCdf function via uniqueProbe parameter. Possible values are
FALSE for not unique probes, TRUE for unique probes.

•

Share probe between transcripts of a gene: In the case of transcript based custom
CDFs, when an exon is shared between transcripts of a gene, only one of them can
have probes that maps to the exon because we choose one of the annotations that a
probe maps and remove the remaining matches (See chapter 6 for more details).
Via share probe between transcript of a gene option, probe sharing between
transcripts of a gene is allowed. This option is provided to cover more transcripts
in the CDF and supply more accurate predictions for every transcript of a gene via
having more probes per probe set.

The last option that creates diverse CDF is junction tolerance.
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•

Junction tolerance file: Junction tolerance allows CDFs to include probes that
map to the junctions of annotations via merging overlapping and consecutive
intervals of same structures before creating NCList indexes. For example, in
Rat assembly rn6 the PRR4 gene has four transcripts. One of the transcripts
(ENSRNOT00000078821) has an exon (ENSRNOE00000523383) that starts at
167,483,620

and

ends

at

167,483,880.

Another

transcript

(ENSRNOT00000038396) has an exon (ENSRNOE00000557210) that starts at
167,483,881 and ends at 167,483,910. When junction is not allowed, a probe in
Rat 230 2.0 microarray with 167,483,620 and 167,483,887 coordinates will not
be annotated with PRR4-exon because it does not align to an individual exon.
When junction is allowed a new interval 167,483,620 and 167,483,910 will
represent the PRR4-exons and the probe will be annotated and placed in the
produced custom CDF.
7.1.2 Interpreting Results
The affyCustomCdf tool produces three files. They are custom CDF file, report file
and missing probes file.
•

Custom CDF file: Produced custom CDF file consists of regrouped probes into
probe sets based on specific annotations of interest. It is used for data analyses
of Affymetrix® GeneChip® data.

•

Report File: Report file consists of multiple information. They are:
o Parameter values sent to the CreateAffyCustomCdf function.
o Distribution of number of probes per probe set table.
o The histogram of the number of probes per probe set.
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o Number of probes aligned to an annotation.
o Number of annotation detected by probes before probe sharing
eliminated.
•

Missing Probes File: In some cases, the FASTA file of probes may include
some probes that is not used in the original CDF. These probes are detected and
placed into a text file to inform users. The name of the file starts with the
original

CDF

name

with

postfix

missingProbes.

i.e

Rat230_2.cdf_missingProbes.txt
7.1.3 Running Time
As long as the version of a genome and annotations are not changed, probe sets
designed inside the custom CDFs are not required to be created more than one time
providing that in Affymetrix® GeneChips® probes do not change. Therefore, long running
time does not become an important issue. But still we know that short running time is
always a positive feature to have in a tool. To achieve relatively fast tool, we took the
advantage of NCList indexing and hash tables. Moreover, we implemented some part of
the tool with C++ and combined these parts with R code. Table 11 shows the running time
result in seconds performed on a computer with eight GB memory and 2.80 GHz CPU.
TABLE 11: Running times
Region Based Gene Based Transcript Based
Human U133 Plus 2.0 Array
23 min
23 min
4 min
Rat Genome 230 2.0 Array
6 min
6 min
71.82 sec
Mouse Genome 430 2.0 Array
13 min
14 min
3 min
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Figure 46: affyCustomCdf parameter selection
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CHAPTER 8
EXPERIMENTAL RESULTS
In this section we demonstrate the remapping and probe set results for some of our
custom CDFs. We also include analysis results performed by using our custom CDFs. The
experiments were performed on the Affymetrix® GeneChip® HG-133 Plus 2, Rat 230 2.0.
and Mouse 430 2.0. During the creation of custom CDFs, no direction rule is applied and
junction is not allowed (see Section 7.1.1 custom CDF types).
8.1 Probes Mapping to Genome
Using the bowtie version 1.0.1 we were able to identify probes that uniquely map
with 100% identity for each of the respective genomes. As a result, 87% PM probes of the
HG-U133 Plus 2, 84% PM probes of the Rat 230 2.0 and 86% PM probes of the Mouse
430 2.0 were uniquely mapped to the genome and were used in the subsequent steps (Table
12).
TABLE 12: Number of mapped probes for custom CDF construction

GeneChip®

# of PM Probes
# of PM # of PM Probes
# of PM Probes
Mapped to Multiple
Probes Mapped Uniquely
Not Aligned
Locations
603,158 525,985
364,93
406,80

Human Genome U133
Plus 2.0 Array
Rat Genome 230 2.0
341,459 288,319
Array
Mouse Genome 430 2.0 495,374 427,758
Array
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260,27

271,13

284,44

391,73

8.1.1 HG-133 Plus 2
Chromosome sequences of the human assembly 38 (October 2014) were obtained
from the Ensembl ftp and bowtie indexes were created using bowtie-build version 1.0.1
with default parameters. We also obtained the DNA sequences for perfect match (PM)
probes of Affymetrix® GeneChip® HG-U133 Plus 2 from the Affymetrix® Netaffx™ web
site as a FASTA file format. After we removed the control probes from FASTA file, we
performed mapping of PM probes to the indexed genome using Bowtie version 1.0.1
(parameters –v 0 – m 1). We filtered all the probes except those that aligned to one genomic
location with 100% identity. As a result, 525,985 out of 603,158 PM probes uniquely
mapped to the genome and were used in the next steps. 36,493 probes mapped to multiple
locations and were removed. 40,680 PM probes did not align to the genome without
mismatches and were also removed.
8.1.2 Rat 230 2.0
Chromosome sequences of rat assembly Rnor 6 were obtained from NCBI and
created bowtie indexes using bowtie-build version 1.0.1 with default parameters. We also
obtained the DNA sequences for the perfect match (PM) probes of Affymetrix®
GeneChip® Rat 230 2.0 from the Affymetrix® Netaffx™ web site in FASTA file format.
After we removed the control probes from the FASTA file, we performed mapping of PM
probes to the indexed genome using Bowtie version 1.0.1 (parameters –v 0 – m 1). We
filtered out all the probes except ones that aligned to one genomic location with 100%
identity. As a result, 288,319 out of 341,459 PM probes uniquely mapped to the genome
and were used in the next steps. 26,027 probes mapped to multiple locations and were
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removed. 27,113 PM probes did not align to the genome without mismatches and also were
removed.
8.1.3 Mouse 430 2.0
Chromosome sequences of Mouse assembly mm10 were obtained from the
Ensembl ftp and created bowtie indexes using bowtie-build version 1.0.1 with default
parameters. We also obtained the DNA sequences for the perfect match (PM) probes of
Affymetrix® GeneChip® Mouse 430 2.0 from the Affymetrix® Netaffx™ web site in
FASTA file format. After we removed the control probes from the FASTA file, we
performed mapping of PM probes to the indexed genome using Bowtie version 1.0.1
(parameters –v 0 – m 1). We filtered out all the probes except ones that aligned to one
genomic location with 100% identity. As a result, 427,758 out of 495,374 PM probes
uniquely mapped to the genome and were used in the next steps. 28,444 probes mapped to
multiple locations and were removed. 39,173 PM probes did not align to the genome
without mismatches and also were removed.
8.2 Probe Annotations and Probe Sets
To annotate probes, we mapped uniquely aligned probes to gene regions using the
Ensembl GTF file for each respective organism. We selected the specific regions from GTF
based on the custom CDF type (gene, transcript or region-based). Consequently, we
produced three types of custom CDFs (Tables 13 and 14).
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TABLE 13: Summary of probes used for custom gene and transcript based Custom CDFs
Homo sapiens
Rattus norvegicus Mus musculus
Gene Transcript Gene Transcript Gene Transcript
# of Probes
414,701 504,419 162,356 205,671
Used
# of Probe Sets 226,51 260,96 131,50 144,66
Constructed
Average # of
18
18
12
14
Probes Per
Probe Set

323,917

395,884

192,82

209,80

16

18

TABLE 14: Summary of probes used for region based custom CDFs

Homo sapiens Rattus norvegicus
# of Probes Aligned to Genome
# of Probes Used
# of Probe Sets Constructed
Average # of Probes Per Probe
Set

822,681
414,701
339,16
12

321,905
162,356
198,39
8

Mus
musculus
637,942
323,917
289,63
11

8.2.1 Detailed Results for HG-133 Plus 2
We used the Ensembl GRCh38 genome version’s GTF file for the annotations and
created three different CDF files for future data analysis.
I.

Region Based Custom CDF
After mapping probes to the genomic regions, we identified 822,681 annotations (a

probe aligned to a genomic region and marked with this region). The custom CDF has
33,939 custom designed probe sets: 16,375 probe sets represent UTR regions and 16,024
probe sets represents exon, plus 62 original control probe sets. 405,020 annotations were
filtered.
Fig. 47 shows the distribution of probe numbers per probe set. The minimum probe
number per probe set is 1, the average number of probes per probe set is around 12 and the
median is 11.
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Figure 47: The distributions of probe numbers per probe set for the gene region based
CDF
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II.

Gene Based Custom CDF
The human gene based CDF has 22,651 custom designed probe sets composed from

414,692 probes and 62 original control probe sets. 442,025 annotations were identified
between genes and the probes. 27,324 annotations were filtered after shared probes were
removed.
In order to validate our probe set annotations, we compared the original CDF probe
sets with the custom CDF. A total of 21,585 annotated genes were shared between the two
CDFs, with 3,068 unique to the original CDF, and 1,066 unique to our custom CDF. We
obtained the Ensembl id for each probe set from the Ensembl Funcgen database [109] using
Perl scripts. Fig. 48 shows the comparison results. 85% (except control probes) of the
original probe targets are preserved in the custom CDF.

Figure 48: Original CDF versus custom CDF
To determine why some genes were not covered in our CDF, we examined those
unique to the original CDF. First, we obtained the probe sets which represent these genes
in the original CDF, yielding 2,781 probe sets. We retrieved both the PM and MM probe
109

sequences for each of these. We observed that for 667 probe sets, every probe was removed
during probe mapping to the genome due to either non-unique mappings or mapping rates
less than 100%. 30,150 probes from the remaining 2,114 probe sets were not used in our
CDF since they either did not map to the genome or they were MM probes. 14,028 probes
were used in our newly constructed probe sets which target different genes than the original
assignment by Affymetrix® and 2,656 probes were not aligned to gene structures and not
annotated. As a result, the differences between the original CDF and our method occurs
because of probes removed during genome alignment, probes that no longer map to gene
structure or probes that map to gene structures different from the original annotation.
Fig. 49 shows the distribution of probe numbers per probe set. The minimum probe
number per probe set is 1, the average number of probes per probe set is around 18 and the
median is 11.
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Figure 49: The distributions of probe numbers per probe set for the gene based CDF
We also compared our gene based CDF with the Brain Array Ensembl Gene version
19 CDF (Fig. 50). Most of the genes that were not included in our CDF were removed
during the filtering of multiple annotated probes. A few of the missing genes are located
on the mitochondrial Chromosome MT which is not included in our Bowtie index. We
annotated an additional 2,758 genes.

Figure 50: Original CDF versus the brain array CDF
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III.

Transcript Based Custom CDF
The unique probes transcript based CDF has 26,096 custom designed probe sets

composed from 504,419 probes. We also included 62 original control probe sets. 2,129,643
annotations were identified between transcripts and the probes.
Fig. 51 shows the distribution of probe numbers per probe set. The minimum probe
number per probe set is one, the average number of probes per probe set is around nineteen
and the median is eleven.

Figure 51: The distributions of probe numbers per probe set for the transcript based CDF
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8.3 Analysis Results
To test our custom CDFs, we reanalyzed the publicly available data series
GSE72551 and GSE48611. Both studies involve the nervous system, where differences in
3’ UTRs are likely to have phenotypic effects on transcript localization. We tested it on the
publicly available data series. The GSE48611 data set was analyzed via HG-133 Plus 2
custom CDFs. The GSE48611 was analyzed via Rat 230 2.0 custom CDFs. Prior to
analysis, we removed probe sets with two or fewer probes from the custom CDFs in order
to achieve more accurate results for target expression levels. Robust Multiarray Averaging
(RMA) normalization was used for preprocessing. A p-value 0.05 was used as the threshold
for all experiments.
•

Results for GSE48611
The GSE48611 [63] was obtained from GEO. The data series examines Down

Syndrome (trisomy 21) gene expression monitoring. They have collected mRNA samples
from the isogenic trisomy of chromosome 21 (Ts21) and control pluripotent stem cells
(iPSCs) (DS1, DS4, and DS2U) between passages 24 and 48 and from day 30 neurons.
They have three biological replicates for each case. In our analysis we looked for the
differentially expressed genes (DEGs) between isogenic Ts21 and control iPSCs for DS1
and DS4. To identify the DEGs, we set an adjusted p-value threshold of 0.05 for all
experiments and obtained the genes passing this threshold. Before starting the analysis, we
removed the probe sets which have 3 or fewer probes per probe set from custom CDFs.
First, we analyzed the data based on our gene based custom CDF and the original
Affymetrix® supplied CDF obtained from the Affymetrix® Netaffx™ web site. For DS1,
our gene based CDF identified 814 DEGs, while the original CDF identified 2,402 DEGs
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with 625 DEGs identified by both methods (Fig. 52). Table 15 shows the top ten DEGs
and their ranking in the original method results. Since the original CDF has multiple probe
sets per gene, we only reported the top ranking for each gene and adjust the rankings. We
have two genes (ZNF717, ZNF560) in our top ten list from qPCR verified genes which is
supplied in the original paper.
We repeated the same analysis for DS4 versus DS2U. Our gene base CDF identified
621 DEGs, while the original CDF identified 1,819 unique DEGs with 379 DEGs identified
by both methods (Fig. 53). Table 16 shows the top ten DEGs based on our CDF and their
adjusted ranking in the original method results. We have three genes (ZNF717, ZNF560,
CRYZ) in our top ten list from qPCR verified genes which is supplied in the original paper.
Eight genes were commonly expressed for DS1 and DS4.

Figure 52: Typical method versus our method for DS1 versus DS2U
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TABLE 15: DS1 versus DS2U top ten DEGs
Our Method
Gene Id

logFC

ZNF667-AS1
CTSF
ZNF667
ZNF717
NNAT
ZNF560
TMSB15A
ZNF578
ZNF239
PAXBP1

5.682693
1.906976
3.579938
3.209391
3.445
2.764886
-2.28818
1.990097
-2.1717
1.057482

Original Method

adj.P.Val Ranking
1.50E-08
4.24E-08
4.19E-07
6.06E-07
2.62E-06
5.54E-06
6.54E-06
1.80E-05
1.80E-05
1.86E-05

1
2
4
16
18
7
NA
19
13
23

logFC

adj.P.Val

5.617611
2.074571
3.910541
2.355922
2.125069
2.638967
NA
1.940997
-2.19910
1.000226

5.53E-09
2.89E-08
8.74E-07
2.96E-05
3.45E-05
1.97E-06
NA
3.52E-05
2.39E-05
4.57E-05

Figure 53: Typical method versus our method for DS4 versus DS2U
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TABLE 16: DS4 versus DS2U top ten DEGs
Our Method
Gene Id
ZNF717
ZNF667-AS1
NNAT
ZNF578
CTSF
NLRP2
PAXBP1
CRYZ
ZNF560
SRP19

logFC
3.316176
3.97883
3.591202
2.205069
1.233071
1.575696
0.977935
5.230353
2.220455
-0.86613

Original Method

adj.P.Val Ranking
1.50E-06
1.57E-06
2.38E-06
8.71E-06
1.04E-05
1.04E-05
7.41E-05
7.41E-05
8.07E-05
0.000161

8
1
10
7
6
5
19
11
9
33

logFC

adj.P.Val

2.564958
2.25E-05
3.996053
1.14E-06
2.221193
4.02E-05
2.167641
2.25E-05
1.292598
1.34E-05
3.454983
8.77E-06
0.862839 0.000480611
5.240513
7.67E-05
2.166272
3.74E-05
-0.81259 0.001628958

We analyzed DS1 versus DS2U via our region based CDF as well. The CDF
identified 1,494 DE gene regions. 56 DE gene regions target the same gene but different
regions (UTR and exon) (Fig. 54). 698 of them only come from UTR and 740 of them did
not have probe sets in UTR region (i.e. they only come from exon regions). Fig. 55 shows
the result for DS4 versus DS2U.

Figure 54: Distributions of probe set regions in the DS1 versus DS2U DEGs
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Figure 55: Distributions of probe set regions in the DS4 versus DS2U DEGs
In order to see how the region based CDF changes the analyses, we took the
Ensembl id of every region probe set and compared them with the Ensembl id of the gene
based result (Fig. 56, Fig 57). It showed that the number of commonly detected DEGs is
small compared to the number of detected DEGs in each case.

Figure 56: Distribution of common and different DEGs for our gene and gene region
based methods in the DS1 versus DS2U case
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Figure 57: Distribution of common and different DEGs for our gene and gene region
based methods in the DS4 versus DS2U case
Table 17 shows the top ten DEGs for DS1 versus DS2U. Table 18 shows the top
ten DEGs for DS4 versus DS2U. In the case of Ds4 versus the DS2U region based three
genes of top ten are same with D1 versus DS2U region based.
TABLE 17: DS1 versus DS2U top ten region based DEGs
Region Method
Probe Name

Gene Id

logFC

ENSG00000154646_UTR_-

TMPRSS15

ENSG00000143473_exon_ENSG00000135916_UTR_+

Gene Method

adj. P.Val

Ranking

adj.P.Val

1.618164

4.33E-06

13712

0.763167

KCNH1

1.506579

4.33E-06

15435

0.825465

ITM2C

3.143009

1.77E-05

7385

0.468028

ENSG00000232837_exon_-

AF064858.7

1.312395

0.000157

12364

0.709271

ENSG00000122085_exon_-

MTERFD2

1.582542

0.000157

6532

0.419254

ENSG00000229913_exon_-

RP11-378I13.1

1.778681

0.000157

13950

0.771693

ENSG00000184361_UTR_-

SPATA32

0.896036

0.000157

21500

0.998295

ENSG00000224418_exon_+

STK24-AS1

0.912373

0.000192

12250

0.704311

ENSG00000174915_UTR_+

PTDSS2

1.644557

0.000215

10517

0.630927

ENSG00000204179_UTR_+

PTPN20

1.340051

0.000215

3403

0.212167
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TABLE 18: DS4 versus DS2U top ten region based DEGs
Region Method
Probe Name

Gene Id

logFC

adj P.Val

ENSG00000154646_UTR_-

TMPRSS15

1.117224

ENSG00000215644_exon_+

GCGR

5.114162

ENSG00000143473_exon_-

KCNH1

ENSG00000265491_exon_-

RNF115

ENSG00000224418_exon_+
ENSG00000160294_exon_-

Gene Method
Ranking

adj. P.Val

0.000477

859

0.058301

0.000477

18359

0.921109

1.044703

0.000477

14504

0.790649

-1.2177

0.000557

16520

0.862608

STK24-AS1

0.857835

0.000603

15478

0.828281

MCM3AP

1.042106

0.000603
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0.010939

ENSG00000113384_UTR_-

GOLPH3

1.170004

0.000737

18153

0.799779

ENSG00000132016_UTR_-

C19orf57

1.451636

0.000831

8375

0.505504

ENSG00000099219_UTR_-

ERMP1

-0.98893

0.000869

16003

0.849883

ENSG00000227234_exon_+

SPANXB1

-1.01635

0.000869

19103

0.941769

We also used the Brain Array Ensembl Gene version 19 custom CDF to compare
our method’s gene based results. 712 genes detected as DE by both methods (Fig. 58). Our
method detected 189 unique DEGs and Brain array detected 182 unique DEGs.

Figure 58: DEGs detected by the Brain array method and our gene based method for DS1
versus DS2U
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TABLE 19: D1 versus DS2U top ten upregulated genes Brain Array Ensembl V 19
External Id

logFC

CTSF
ZNF667
ZNF667-AS1
NNAT
ZNF560
TMSB15A
ZNF239
PAXBP1
ZNF578
UTY

1.897594
3.530854
5.134179
2.84469
2.741947
-2.29051
-2.27282
1.129587
1.986575
1.968354

adj.P.Val Our Method Rank
1.06E-07
6.31E-07
1.22E-06
2.68E-06
6.39E-06
6.89E-06
6.89E-06
1.52E-05
1.68E-05
2.81E-05

2
3
1
5
6
7
9
10
8
11

Nine out of ten genes correlate with our results. The UTY gene is detected as the
11th DEG.
•

Results for GSE72551
The GSE72551 data series examines gene expression changes associated with

collateral sprouting and includes 5 naive controls, 7 replicates at day 7 post-surgery and 7
replicates at day 14 post-surgery. In our analysis we looked for the differentially expressed
genes (DEGs) between 0-7 and 0-14. To identify the DEGs, we set a p-value 0.05 as the
threshold for all experiments and obtained the genes passing this threshold. Before starting
the analyses, we removed the probe sets which have less than three probes from custom
CDFs. First, we analyzed the data based on our gene based custom CDF and original
Affymetrix® supplied CDF obtained from the Affymetrix® Netaffx™ web site. For 7
versus 0, our gene base CDF identified 981 DEGs; original CDF identified 1,695 unique
DEGs. 750 DEGs identified by both methods (Fig. 59). Table 20 shows the top ten DEGs
and their ranking in the original method results. For 14 versus 0, our gene base CDF
identified 1,948 unique DEGs, original CDF identified 3,484 unique DEGs. 1,560 DEGs
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identified by both methods (Fig. 60). Table 21 shows the top ten DEGs and their ranking
in the original method results.

Figure 59: Typical method versus our method for day 7 versus naive

Figure 60: Typical method versus our method for day 14 versus naive
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TABLE 20: Day 7 versus naive top ten DEGs
Our Method
Gene Id logFC
Slc41a2
Txnrd1
Nppa
Grhl3
Bdnf
Rasgrp2
Abca8a
Pdzd3
Gabra5
Cat

Original Method

P.Val

0.327865
0.30567
0.400947
-1.11758
0.754445
-0.34898
-0.29425
-0.37835
0.721666
-0.29616

Ranking

logFC

P.Val

5
13
8
3
10
45
15
11
15
22

0.331196
0.323269
0.410406
-1.02727
0.793467
-0.38074
-0.28487
-0.38425
0.742534
-0.29166

4.05E-05
7.61E-05
5.19E-05
2.80E-05
6.86E-05
0.000517
0.000117
6.98E-05
8.59E-05
0.00021

1.87E-05
2.16E-05
4.26E-05
4.97E-05
5.93E-05
6.34E-05
0.000104
0.000114
0.000138
0.000156

TABLE 21: Day 14 versus naive top ten DEGs
Our Method
Gene Id

logFC

P.Val

AABR07026969.1 -0.56774 8.43E-07
Bbs5
-0.54004 6.47E-06
Pde7b
0.374652 7.25E-06
Epb41l4a
-0.37437 1.58E-05
Tgs1
-0.39079 1.95E-05
Txnrd1
0.307737 1.99E-05
Pcsk6
-0.28696 2.37E-05
Wdr75
-0.3425 2.40E-05
Tmem18
-0.37817 3.31E-05
Cish
0.293301 4.15E-05

Original Method
Ranking

logFC

P.Val

5
27
29
16
35
64
24
34
2018
162

0.331196
-0.4116
0.339101
-0.3719
-0.38539
0.308068
-0.28712
-0.38832
-0.23385
0.41206

4.05E-05
2.94E-05
3.49E-05
1.41E-05
5.32E-05
0.000131
2.77E-05
5.17E-05
0.009632
0.000387

We analyzed the data via region based CDF as well. For condition 7, the CDF
identified 1,350 DE gene regions. 94 DE gene regions target the same gene but different
regions (UTR and exon) (Fig. 61). 695 of them only come from UTR and 561 of them did
not have probe sets in UTR region (i.e. they only come from exon regions).
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Figure 61: Distributions of probe set regions in the 7 versus naive DEGs
For condition 14, the CDF identified 2,573 DE gene regions. 248 DE gene regions
target the same gene but different regions (UTR and exon) (Fig. 62). 1349 of them only
come from UTR and 976 of them did not have probe sets in UTR region (i.e. they only
come from exon regions).

Figure 62: Distributions of probe set regions in the 14 versus naive DEGs
In order to see how the region based CDF changes the analyses, we took the
Ensembl id of every region probe set and compared them with the Ensembl id of the gene
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based result (Fig. 63, Fig. 64). It showed that the number of common detected DEG is small
compare to number of detected DEGs in each case.

Figure 63: Distribution of common and different DEGs for our gene and gene region
based methods in the 7 versus naive case

Figure 64: Distribution of common and different DEGs for our gene and gene region
based methods in the 7 versus naive case
Table 22 shows the top ten DEGs for 7 versus naive. Table 23 shows the top ten
DEGs for 14 versus naive.
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TABLE 22: 7 versus naive top ten region based DEGs
Region Method

Gene Method

Probe Name

Gene Id

logFC

P.Val

Ranking

P.Val

ENSRNOG00000018225_UTR_+

Tp53inp2

0.445475

2.34E-05

7909

0.573936

ENSRNOG00000002327_UTR_-

Gabrb1

0.813037

2.69E-05

10404

0.805792

ENSRNOG00000045989_exon_-

LOC287167

0.628027

3.07E-05

8949

0.666452

ENSRNOG00000020076_exon_+

RGD1311783

0.32314

4.15E-05

738

0.03043

ENSRNOG00000002336_exon_+

Gabra4

0.736634

4.47E-05

2792

0.155193

ENSRNOG00000016847_UTR_+

Bace1

0.756573

5.99E-05

6593

0.46302

ENSRNOG00000014312_exon_+

TRBC2

-0.87884

7.60E-05

8180

0.596293

ENSRNOG00000060599_UTR_+

Gabrb3

0.645368

0.000113

1281

0.058284

ENSRNOG00000006027_exon_+

Eif2ak4

0.308961

0.000129

6730

0.476479

ENSRNOG00000010361_UTR_+

Kif3b

0.23965

0.000148

4056

0.251742

TABLE 23: 14 versus naive top ten region based DEGs
Region Method

Gene Method

Probe Name

Gene Id

logFC

P.Val

Ranking

P.Val

ENSRNOG00000020877_UTR_-

Pyy

-0.77755

5.943563

521

0.005948

ENSRNOG00000024452_UTR_+

Rltpr

-0.60557

6.594111

9979

0.681486

ENSRNOG00000054080_exon_-

Cgnl1

-0.45831

8.026746

11422

0.861384

ENSRNOG00000060931_exon_-

Rspy1

-0.36454

10.27095

1096

0.017312

ENSRNOG00000002327_UTR_-

Gabrb1

0.839938

8.305223

2309

0.051623

ENSRNOG00000015231_UTR_+

Mrpl44

0.284317

9.885974

7862

0.446372

ENSRNOG00000025496_exon_+

Usp7

-0.72064

5.742713

8428

0.501202

ENSRNOG00000002336_exon_+

Gabra4

0.773239

8.259599

301

0.00283

ENSRNOG00000013956_exon_-

Rnf38

-1.34435

6.044207

9180

0.586421

ENSRNOG00000014312_exon_+

TRBC2

-0.94034

5.994768

2577

0.062007

We also reanalyzed the data using brainarray Ensembl CDF version 20. Fig. 65
shows a Venn diagram representing the number of differentially expressed genes using
region, gene and brainarray custom CDFs for both cases.
Further examination of the 7 day versus naive ENSEMBL genes found to be
differentially expressed in either the gene-based or region-based CDF shows high
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concordance, with 975 ENSEMBL genes determined to be differentially expressed using
both CDFs (Fig. 65a). Examination of the p-values shows a significant correlation between
both the gene and the 3’ UTR region (r=0.439; p=1.480E-58) as well as the gene and the
exon region (r=0.101; p=0.001). The higher correlation with the 3’ UTR region is to be
expected, due to a higher abundance of probes designed in these regions.
160 genes are found to be differentially expressed using the gene-based approach
only, with three not included in the region-based CDF. Further examination shows that 122
of these (78%) have a gene-based pvalue > 0.03, and 80 (50%) have a gene-based p-value
> 0.04, indicating the detected differences are just below the cutoff level. Analysis of the
region-based p-values show that 120 of these (77%) have a region based p-value < 0.10,
and 146 (94%) have a region-based p-value < 0.20, putting these genes just above the
significance threshold.
An additional 423 genes are found to be differentially expressed using the regionbased approach only, with 203 from the 3’ UTR only, 10 from the 5’ UTR only, 206 from
the exon only, and 4 from both the 3’ UTR and exon. Unlike the DEGs uniquely found in
the gene-based approach, those genes found to be differentially expressed in the regionbased approach typically have a much higher p-value in gene-based analysis, with only
31% having a p-value between 0.05 and 0.10. This supports our reasoning that separating
into functional regions allows detection of subtle changes in transcript formation that may
have a larger functional impact of those transcripts which has been further validated by
experimental work showing differential expression of the 3’ UTR of the CAMKIV gene
plays a role in localization [110].
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Figure 65: Number of common and different differentially expressed genes using region,
gene and brain array custom CDFs. a Day 7 versus naïve. b Day 14 versus naive
In order to determine why some genes were only detected by brainarray, we
examined probes of those genes. 39 probes were not used in our CDFs since they aligned
to multiple locations in the rn6 genome. 10 probes did not match gene structures in Ensembl
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and were not used in the CDFs. 18 probes were removed because the probe set contained
fewer than three probes. 40 probes were used in different probe sets other than those
annotated by brainarray.
8.4 Conclusions
One of the limitations of microarray technologies is the design of probes based on
available sequence and annotation data at the time of design. Based on our analysis, the
percentage of uniquely mapping probes varies from 84% (rat) to 87% (human), indicating
that changing knowledge about the genome itself plays a role in probe utilization. In terms
of annotation, the rat genome is known to have more incomplete information when
compared to mouse and human, which is reflected in the fact that only 47% of the rat probes
lie in region-based locales (exons and UTRs) compared to 65% for mouse, and 69% for
human. Since this can potentially lead to a small number of probes in each annotated region
(and thus increased false positive rates), we have further required at least three probes be
present in each probe set for our analysis. To further illustrate the importance of regionbased CDFs, using the subset of 4,024 genes with probesets in both the individual exon
and 3’ UTR regions, we were able to identify 203 differential expression events at the 3’
UTR level that do not show differential expression within the exon. In addition, these
events are not detected using the standard Affymetrix® CDF. Further analysis of these 203
genes yields some genes of particular interest. For instance, the 3’ UTR of GRIK4
(Glutamate Ionotropic Receptor Kainate Type Subunit 4) was up-regulated (p-value
0.0450) while the CDS was not significantly regulated (FC=1.07; p-value 0.4525),
suggesting the 3’ UTR of this gene was lengthened (Fig. 66). GRIK4 regulates kainitereceptor signaling and neuroplasticity [111] and its missregulation is associated with
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neurological diseases including Alzheimer’s, bipolar disorder [112], and others.
Interestingly, a deletion variant specific to the 3’ UTR of GRIK4 is protective of bipolar
disorder[112]. Alongside our observation, this shows an example of how a gene can be
regulated through the 3’ UTR. We also observed that the 3’ UTR of VEGFA (vascular
endothelial growth factor-A) was downregulated (-1.17 FC; p=0.0102) and expression of
its CDS was unchanged (1.01 FC; p=0.8334) (Fig. 66). The 3’UTR of VEGFA, a potent
neuromodulator, undergoes a well-described binary switch to regulate its expression [113].
Our observations suggest the VEGFA 3’ UTR undergoes an additional layer of regulation
by shortening during collateral sprouting.
As our analysis with the GSE48611 and GSE72551 datasets show, reanalysis of
publicly available datasets using updated annotations can yield additional information
when compared to the use of the original CDFs. In our case, the region-based CDFs allow
for a better understanding of 3’ UTR dynamics through the reanalysis of publicly available
data. While current high-throughput sequencing technologies may allow for a more
complete picture, this custom CDF approach will allow for deeper insight with only
minimal computational cost, taking advantage of the high volume of publicly available
GeneChip® data.
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Figure 66: Probe set expression levels within the gene, exon, and 3’ UTR regions for 12
different genes
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CHAPTER 9
CONCLUSIONS AND FUTURE DIRECTIONS
Microarrays were designed to examine the gene expression at the level of exons
and genes but they do not examine the genes at the untranslated regions (UTRs).
Additionally, they do not supply gene expression on transcript levels. Several researchers
have called attention to the importance of getting expression levels for a specific transcript
and created their own Chip Description Files (CDFs) to redesign probe sets. However, to
this point in time analyses at the level of UTRs and individual exons has been minimal. It
has been revealed that the untranslated regions of mRNA can dramatically change the
regulation of protein and result in abnormal cell functions later on diseases. For that reason,
achieving genome based screening of publicly available microarray data at the level of
gene regions is important. Moreover, one of the limitations of microarray technologies is
the design of probes based on available sequence and annotation data at the time of design.
Based on our analysis, the percentage of uniquely mapping probes varies from 84% (rat)
to 87% (human), indicating that changing knowledge about the genome itself plays a role
in probe utilization. The significant differences between old and new genome assemblies
and annotations make it necessary to update probe-gene targeting according to current
knowledge to get more accurate interpretations from experimental results. In order to make
it these possible, we created new CDFs by reassigning probes at the level of UTRS and
individual exons. Moreover, we developed a tool for dynamically creating custom CDFs
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based on the user’s interest. We believe that our work will help researchers to reexamine
already analyzed data in a different way
9.1 Summary of Contributions
•

We developed an Affymetrix® GeneChip® probe remapping protocol at the level of
genes, transcripts, untranslated regions (UTRs) and individual exons based on the latest
genome (hg38, mm10, rn6) and Ensembl annotations for human, mouse, and rat. Our
results illustrated how this framework affects the detection of differentially expressed
genes, particularly when focusing on functional regions of interest. Removing probes
that do not perfectly align to the genome or align to multiple locations can help to
reduce false-positive differential expression, as can removal of probes in regions
overlapping multiple genes.

•

The main motivation of our work was profiling the contribution of UTR and exon
regions to the gene expression levels globally. Our results indicate that features
differentially expressed in either the gene-based or region-based CDF shows high
concordance and separating out into functional regions allows for the detection of
subtle changes in transcript formation.

•

Our method can detect changes that would have been missed if the analysis was not
separated into functional regions. For example, as shown in fig. 66 the 3’ UTR of the
VEGFA gene upregulates between day zero to day seven, however the exon regions of
the VEGFA does not show a significant change.

•

We developed an R package, affyCustomCdf, for allowing users to dynamically create
custom CDFs. This is important since genomic knowledge grows and improvs very
fast. For example, when we performed analyses with our custom CDFs, the latest
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Ensembl version was 85. Currently, Ensembl version 92 is available. Through the
dynamic nature of our tool affyCustomCdf, user can easily benefit from the
improvement over genomic knowledge and keep custom CDFs updated.
•

Our custom CDF approach allows for deeper insight with only minimal computational
cost, taking advantage of the high volume of publicly available GeneChip® data.

9.2 Post Dissertation Work
9.2.1 Dealing with Dynamic Biological Initializers
Some of the probe sequences may contain single nucleotide polymorphisms (SNPs)
or may map to gene regions that produce variations of RNA products through a molecular
process called RNA editing. It would be informative to query these probes and inform
scientists about possible RNA editing effects within their analysis. These probes can be
detected by mapping probes to the RNA editing site and SNP databases such as dbSNP.
After identification of such probes, a special naming pattern could be used to mark probe
sets containing these probes. Moreover, alternative probe sets can be created via modifying
probes based on known RNA editing sites and SNPs and placed into custom CDFs.
9.2.2 Conservation of Gene Annotation
Some species or some genes of a species might be studied and annotated less than
others. The number of annotated regions in a genome effect the number of probes used in
a CDF because the probes that align to an unannotated region are going to be discarded in
the proposed method. As seen in table 24 the number of probes annotated to a specific
region is higher for the human genome which is well studied while there is likely to be
differences in the number and construction of the gene between human and rat, the
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transcriptomes are still highly similar. The most likely reason for the difference is
incomplete annotation for rat.
TABLE 24: The number of probes per region and transcript after the annotation step
UTR
CDS
Exon Transcript
Human 268,863 108,960 440,252 2,129,643
Rat
100,774 56,425 163,498 275,588
In order to overcome the issue and gain discarded probes back, one can provide
annotations to nonannotated regions of conserved genes across species by converting
genome coordinates and genome annotations between two or more species.
For example, Fig. 67 shows the alignment of Affymetrix® Rat 230 2.0 probes that
targets the Camk4 gene. The probes (ending in _at) do not align to an annotated region of
the rat and human genomes, but the mouse genome has a long UTR region annotation. If
one can use annotations obtained from the mouse genome and apply them to the rat and
human genomes, more probes can be added into probe sets.

Figure 67: Genome browser view of the gene Camk4 with probes
Fig. 68 shows the alignment of Affymetrix® Rat 230 2.0 probes that target the
Otud7a gene. In this case, both the human and mouse genomes have annotations for
the probes. When the probes are aligned to the rat genome, they do not match to an
annotation. In this example, mouse and human annotations could be used annotate these
probes.
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Figure 68: Genome browser view of the gene Otud7a with probes
One way to accomplish this mapping is:
I. Retrieve the annotation file for a species from the genome browser.
II. Convert the annotation coordinates to another genome via the Lift Genome
Annotations tool provided by the UCSC Genome browser.
III. Use new annotations during the probe to annotation alignment.
9.2.3 Disease Drug Network Establishment Based on Genomic Expression
Profiles
UTR region sequence and structure can dramatically change the regulation of a
protein and result in abnormal cell functions and diseases. Our region based CDFs can be
used to monitor the changes of UTR regions with different disease states and drug effects
via analyses of whole-genome gene expression data available in the public repositories.
The obtained expression profile similarities of diseases and drugs can be used to generate
large scale disease-disease, drug-drug and disease-drug networks. A similar work has been
done by Hu et al. They collected GEO datasets that is biologically and statistically
comparable samples produced via same Affymetrix® GeneChip®. To avoid having
multiple probe sets for a gene, they blasted probes of each probe set to NCBI RefSeq
database. Based on the average distance of eleven probes to the 3ꞌ end, they classified probe
sets and picked one probe set for each gene. Their first preference for the probe set selection
is the one located on the 3ꞌ UTR, and they continued selection based on the shortest distance
to the 3ꞌ UTR. Via analyses they generated disease and drug expression profiles from GEO
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datasets and generated a large scale disease- drug network. They point out that the network
can help finding new targets to existing drugs in a cost efficient way and drug
target/pathway identification. Similar work can be done via our region based custom CDF
for only untranslated regions of gene to reveal more information about UTRs, diseases and
drugs relationship.
9.2.4 Untranslated Regions Gene Expression Profiling
Microarrays profile the relative differences in gene expression rather than absolute
gene expression detection. Only genes that significantly vary between samples within an
experiment are detected and the rest of the genes are ignored. Because of unknown and
variable sensitivity of each probe set, microarrays do not guarantee that every probe set has
the same dynamic range of gene expression values. As a result of it, comparison made
between genes with different dynamic ranges does not supply accurate results. Creating a
common gene expression profiling from publicly available microarray data via metaanalyses can provide an advantage for more accurate gene expression proofing. Such as a
dynamic range interval can be calculated for each probe set of a specific microarray
platform and the new experiment results can be judged based on the common reference.
Creating common reference to normalize large amount of microarray data was already
developed by many different groups. For example, Seita et al. [48] created an open platform
for

Affymetrix®

mouse

genome

and

made

it

available

via

a

web

site

(https://gexc.stanford.edu/). But none of them analyzed the microarray data based on the
regions of genes. One can use our region based custom CDFs file to achieve common gene
expression profiling for untranslated regions of genes which can give a big advantage for
future experiment design and analyses.
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APPENDIX A
AffyCustomCdf PARAMETERS
A.1 Original CDF
The original CDF of the selected Affymetrix® GeneChip® microarray must be
supplied to the tool by the user. It is used as a source to obtain control probes and PM and
MM tbase and pbase probe information. It is taken via orginalCdfName parameter. It can
be obtained from Affymetrix® NetAffxTM or GEO. As an example, the original CDF file
for Rat 230 2.0 is included inside the scripts directory of the github repository branch
affyCustomCdfFull.
(https://github.com/UofLBioinformatics/affyCustomCDF/tree/affyCustomCdfFull)
A.2 Probe Alignment File
The affyCustomCdf expects probe mapping as a text file. The probe mapping file
consists of one line per probe, each containing five columns of data. Columns must be tab
delimited without a header line. Columns are in the following order: x location of a probe,
y location of a probe, sense/antisense of a probe (-/+), chromosome name and chromosomal
starting location. Fig. 69 demonstrates first ten lines of the Rat 230 2.0 microarray probe
mapping file. The file is included inside the scripts directory of the github repository branch
affyCustomCdfFull.
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Figure 69: First ten lines of the Rat 230 2.0 microarray probe mapping file
A.2.1 Recommended probe mapping text file creation
The DNA sequences for perfect match (PM) probes is obtained from the
Affymetrix® NetaffxTM web site in a FASTA file format. PM probes are aligned to the
genome using Bowtie version 1.0.1 with the parameters -v 0 and -m 1 which returns the
alignment results for the probes that align to one genomic location with 100% identity.
Also, the suppress parameter can be used to eliminate some output for clarity. The
following command line is an example for aligning Rat 230 2.0 PM to Rat assembly rn6.
It suppresses the 5th, 6th and 7th default Bowtie outputs.

Figure 70: Bowtie command line for probe mapping
If the index of the intended genome of an organism is not supplied by Bowtie, the
assembled unmasked genomic DNA sequences of every chromosome can be downloaded
from one of the online repositories such as Ensembl and NCBI and indexes can be created
from DNA sequences via Bowtie-Build version 1.0.1 with default parameters. Fig. 71 show
the one line of mapping result file.
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Figure 71: Mapping result of Bowtie for Rat 230 2. microarray
The file can be formatted via an R script to obtain the proper column arrangement
(Fig. 72). More script examples and data files can be found under the scripts folder of the
github repository branch affyCustomCdfFull with the file name ProbeFileClear.R.

Figure 72: Example R code for clearing Bowtie mapping results
A.3 Obtaining annotation file
The affyCustomCdf tool accepts annotations as a General/Gene Transfer Format
(GTF). In the GTF file, fields must be tab delimited. The GTF format consist of nine
columns of data per feature. The columns are seqname, source, feature, start, end, score,
strand, frame and attribute. Comment lines in the file must start with #. The feature column
is being used to classify probes for gene features. Therefore, region features must contain
transcript, EXON, CDS and UTR key words (not case sensitive). If separation between 3‘
UTR and 5‘ UTR is desired, features must include the direction information such as
three_prime_utr or five_prime_utr. Otherwise annotation will be performed without
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classification of 3‘and 5‘. For more information please check the Ensembl GFF/GTF file
format definition. http://www.ensembl.org/info/website/upload/gff.html. A sample GTF
file can be found in the scripts directory of the github repository branch
affyCustomCdfFull.
A.4 Selecting Parameters
The affyCustomCdf tool takes thirteen parameters. This includes the original CDF
(Section A.1), probe alignment file (Section A.2) and annotation (GTF) file (Section A.3)
which must be supplied by the user. The remaining parameters are optional, with default
value set. The parameters are:
•

orginalCdfName: String type. The original CDF file of the selected Affymetrix®
GeneChip® technology. It can be obtained from Affymetrix® NetAffxTM web site. For
example, Rat230_2.cdf file for the Rat 230 2.0 microarray.

•

probeAlignmentFile: String type. The tab separated probe alignment file. Please see
section A.1 for more details.

•

gtfFileName: String type. The General/Gene Transfer Format (GTF) file name. Please
see section A.3 for more details.

•

newCDFName: String type. Name of the created custom CDF. If the user does not
provide a name, a name will be created based on the template provided in Fig. 73.

•

reportFile: String type. Name of the report file name. If the user does not provide a
name, a name will be created based on the template report_orginalCdfName.txt.
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Figure 73: File naming for custom CDFs
•

controlProbeSetNumber: Number type. The number of control probe sets in the
original CDF. Control probe sets were being designed to check the quality of the
experiment. They can be detected in the CDF based on the probe set names which
usually starts with AFFX prefix such as AFFX_ratb2/X14115_at. If the number of
control probe set is given, they will be included in the custom CDF without changes
otherwise they will not be included. The default value is 0 (not included).

•

minProbeSetNumber: Number type. The minimum number of probes in a probe set.
Probe sets with less than the minimum number will not be included in the custom CDF.
The default value is three.

•

probeLength: Number type. Number of bases in a probe. In most cases length of a
probe is twenty-five. For different sizes, it can be obtained via checking a sequence of
a probe belongs to an Affymetrix® GeneChip®. The default value is 25.

•

SD: Number type. Sense/antisense relationship between probes and annotations.
Possible values are 0 (no direction), 1 (same direction) and any value except 0 and 1
(opposite direction). The default value is 1 (Same direction).
o When SD is 0, direction will not be considered during probes to annotations
mapping.
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o When SD is 1, mapping is performed between same directions such as the sense
probes are being mapped to the sense annotations.
o When SD is any value except 0 and 1, mapping is performed between opposite
directions such as the sense probes are being mapped to the anti-sense
annotations.
•

type = “regionG”: String type. The type of the created custom CDF. Options are
regionG, gene, transcript. Default value is regionG. G
o regionG: When regionG option is selected, probe sets are designed to target a
specific region (exon, UTR) of a gene and consist of probes which map to the
same region of a gene.
o gene: When regionG option is selected, probe sets are designed to target genes
and consist of probes which map to the same gene.
o transcript: When transcript option is selected, probe sets are designed to target
transcripts and consist of probes which map to the same transcript.

•

transcriptShare: Bool type. It defines whether to allow probe sharing between
transcripts of a gene. It can only be used when transcript type is selected. Possible
values are FALSE for not allowing probe share and TRUE for allowing probe share.
The default value is FALSE.

•

junction: Bool type. It defines whether we are adding probes to probe sets that map
onto a junction of a specific region of a gene. It can be used when regionG or gene
option is selected. Options are FALSE for no junction and TRUE to allow junctions.
The default value is FALSE.
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•

uniqueProbe: Bool type. It defines whether to use probes that map onto more than one
annotations. It is an option for the user to examine unique probes to one specific
annotation. It can only be used with the regionG type. Possible values are FALSE for
not unique, TRUE for unique. The default value is FALSE.

A.5 Running The affyCustomCdf Tool
To create a custom CDF via affyCustomCdf tool, one must call the
createAffyCustomCdf function after installation of the tool. Fig. 74 shows example R
scripts.

Figure 74: Calling createAffyCustomCdf functio
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